{"content":"<li class=\"n-box-item date-title\" data-end=\"1380167999\" data-start=\"1380081600\" data-txt=\"Friday, December 20, 2019\">Wednesday, September 25, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1299632\" data-ts=\"1380149120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLOW-OLD\" target=\"_blank\">FLOW-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299632-flow-international-to-be-acquired-by-p-e-firm-for-4_05-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flow International to be acquired by P-E firm for $4.05/share</a></h4><ul>     <li>P-E firm American Industrial Partners is paying $4.05/share, or over $200M, to acquire Flow International (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FLOW-OLD\" title=\"Flow International Corporation\">FLOW-OLD</a>). The price represents an <font color=\"green\">8.6% premium</font> to Flow's Wednesday close. (PR)</li>     <li>The all-cash deal is expected to close in early 2014.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299632\" data-linked=\"Flow International to be acquired by P-E firm for $4.05/share\" data-tweet=\"$FLOW-OLD - Flow International to be acquired by P-E firm for $4.05/share https://seekingalpha.com/news/1299632-flow-international-to-be-acquired-by-p-e-firm-for-4_05-share?source=tweet\" data-url=\"https://seekingalpha.com/news/1299632-flow-international-to-be-acquired-by-p-e-firm-for-4_05-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299612\" data-ts=\"1380148687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECOM\" target=\"_blank\">ECOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299612-channeladvisor-announces-product-update-makes-new-highs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChannelAdvisor announces product update, makes new highs</a></h4><ul>     <li>ChannelAdvisor's (<a href=\"https://seekingalpha.com/symbol/ECOM\" title=\"ChannelAdvisor Corp\">ECOM</a> <font color=\"green\">+12.3%</font>) August 2013 Autumn Release product update gives the company's e-commerce merchant clients access to international marketplaces such as the U.K.'s Tesco and Amazon's Chinese and Japanese site; ChannelAdvisor has historically depended heavily on North American activity. Support for more smartphones/tablets and Google's mobile-friendly Enhanced Campaigns AdWords search ad platform has also been added.</li>     <li>Shares soared to new highs once again today. They're now <strong><font color=\"green\">up 185%</font></strong> from a <a href=\"https://seekingalpha.com/currents/post/1043601\" target=\"_blank\">May IPO price</a> of $14.</li>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1273572\" target=\"_blank\">Previous:</a> August client same-store sales data</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299612\" data-linked=\"ChannelAdvisor announces product update, makes new highs\" data-tweet=\"$ECOM - ChannelAdvisor announces product update, makes new highs https://seekingalpha.com/news/1299612-channeladvisor-announces-product-update-makes-new-highs?source=tweet\" data-url=\"https://seekingalpha.com/news/1299612-channeladvisor-announces-product-update-makes-new-highs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299592\" data-ts=\"1380147535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMR\" target=\"_blank\">IMMR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299592-immersion-plus-2_8-percent-ah-following-ceos-cnbc-appearance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immersion +2.8% AH following CEO&#39;s CNBC appearance</a></h4><ul>\n<li>During an appearance on CNBC's <em>Fast Money</em>, Immersion (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IMMR\" title=\"Immersion Corporation\">IMMR</a>) CEO Victor Viegas talked up the value of his company's haptic feedback tech and mentioned Immersion is growing at a 50% Y/Y clip.</li>\n<li>Immersion's Q2 revenue was up 58% Y/Y. <a href=\"http://finance.yahoo.com/q/ae?s=IMMR+Analyst+Estimates\" target=\"_blank\">Analysts expect</a> 54% growth in Q3, and 42% growth in Q4.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1268032\" target=\"_blank\">Previous:</a> Immersion haptic tech used in Samsung smartwatch</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1299592\" data-linked=\"Immersion +2.8% AH following CEO&#39;s CNBC appearance\" data-tweet=\"$IMMR - Immersion +2.8% AH following CEO&#39;s CNBC appearance https://seekingalpha.com/news/1299592-immersion-plus-2_8-percent-ah-following-ceos-cnbc-appearance?source=tweet\" data-url=\"https://seekingalpha.com/news/1299592-immersion-plus-2_8-percent-ah-following-ceos-cnbc-appearance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299542\" data-ts=\"1380146263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAA\" target=\"_blank\">MAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299542-s-and-p-index-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">S&amp;P index changes</a></h4><ul>     <li>Mid-America Apartment Communities (NYSE:<a href=\"https://seekingalpha.com/symbol/MAA\" title=\"Mid-America Apartment Communities Inc.\">MAA</a>) and Monster  Worldwide (NYSE:<a href=\"https://seekingalpha.com/symbol/MWW\" title=\"Monster Worldwide, Inc.\">MWW</a>) are switching S&amp;P index listings; MAA will move into the S&amp;P MidCap 400 while MWW replaces it in the S&amp;P SmallCap 600 after the close of trading Oct. 1.</li>     <li>Other changes to the SmallCap 600: Newpark Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/NR\" title=\"Newpark Resources Inc.\">NR</a>) will replace Arbitron (NYSE:<a href=\"https://seekingalpha.com/symbol/ARB\" title=\"Arbitron, Inc.\">ARB</a>) after the close on Sept. 27, Green Dot (NYSE:<a href=\"https://seekingalpha.com/symbol/GDOT\" title=\"Green Dot Corporation\">GDOT</a>) will replace Colonial Property Trust (NYSE:<a href=\"https://seekingalpha.com/symbol/CLP\" title=\"Colonial Properties Trust\">CLP</a>) and Santarus (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SNTS\" title=\"Santarus, Inc.\">SNTS</a>) will replace Volterra Semiconductor (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VLTR\" title=\"Volterra Semiconductor Corporation\">VLTR</a>) after the close Oct. 1.</li>          <li>MAA <font color=\"green\">+0.7%</font>, GDOT <font color=\"green\">+2.1%</font>, NR <font color=\"green\">+3.2%</font>, SNTS <font color=\"green\">+3.5%</font> AH.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"1299542\" data-linked=\"S&amp;P index changes\" data-tweet=\"$MAA $MAA $MWW - S&amp;P index changes https://seekingalpha.com/news/1299542-s-and-p-index-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1299542-s-and-p-index-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299522\" data-ts=\"1380145214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STX\" target=\"_blank\">STX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299522-seagate-rallies-after-displacing-western-digital-on-longbow-list\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seagate rallies after displacing Western Digital on Longbow list</a></h4><ul>\n<li>Seagate (<a href=\"https://seekingalpha.com/symbol/STX\" title=\"Seagate Technology\">STX</a> <font color=\"green\">+5%</font>) gradually moved higher over the course of the day after Longbow's <a href=\"http://blogs.barrons.com/techtraderdaily/2013/09/25/stx-up-5-longbow-adds-to-best-ideas-replacing-wdc/\" target=\"_blank\">Joe Wittine</a> decided to put the company on his firm's Best Ideas list at the expense of archrival Western Digital (<a href=\"https://seekingalpha.com/symbol/WDC\" title=\"Western Digital Corporation\">WDC</a> <font color=\"green\">+1.2%</font>).</li>\n<li>WDC nonetheless saw moderate gains, perhaps in part because much of Wittine's commentary can be viewed as positive for the hard drive industry at-large.</li>\n<li>Wittine reiterates his belief the hard drive industry bottomed in 1H, and points out non-PC drive sales are eclipsing (slumping) PC drive sales thanks to strong enterprise/branded drive growth. He also sees Seagate and WDC's near-duopoly status allowing the companies to maintain a gross margin in the 27%-32% range, and let future capacity additions lag demand.</li>\n<li>He expects Seagate to continue producing $1.9B/year in free cash flow, and praises its valuation of 7.6x estimated FY14 (ends June '14) EPS.</li>\n<li>In spite of the PC industry's <a href=\"https://seekingalpha.com/currents/post/1130902\" target=\"_blank\">woes</a>, both Seagate and WDC have <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1379943000000&amp;chddm=71500&amp;chls=IntervalBasedLine&amp;cmpto=NASDAQ:WDC&amp;cmptdms=0&amp;q=NASDAQ:STX&amp;ntsp=1&amp;ei=y1dDUuDLBqK5iwL9mwE\" target=\"_blank\">done well this year</a>.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1299432\" target=\"_blank\">Earlier:</a> Western Digital CFO leaving for ASML</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1299522\" data-linked=\"Seagate rallies after displacing Western Digital on Longbow list\" data-tweet=\"$STX $STX $WDC - Seagate rallies after displacing Western Digital on Longbow list https://seekingalpha.com/news/1299522-seagate-rallies-after-displacing-western-digital-on-longbow-list?source=tweet\" data-url=\"https://seekingalpha.com/news/1299522-seagate-rallies-after-displacing-western-digital-on-longbow-list\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299512\" data-ts=\"1380144934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299512-after-hours-top-gainers-losers-as-of-5-15-p-m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers / Losers, as of 5:15 p.m</a></h4><ul>     <li>\n<b>After-hours top gainers, as of 5:15 p.m.:</b> KBIO <font color=\"green\">+5.8%</font>. <a href=\"https://seekingalpha.com/symbol/BBBY\" title=\"Bed Bath &amp; Beyond Inc.\">BBBY</a> <font color=\"green\">+4.5%</font>. <a href=\"https://seekingalpha.com/symbol/AEPI\" title=\"AEP Industries Inc.\">AEPI</a> <font color=\"green\">+3.9%</font>. <a href=\"https://seekingalpha.com/symbol/UEC\" title=\"Uranium Energy Corp\">UEC</a> <font color=\"green\">+3.3%</font>. <a href=\"https://seekingalpha.com/symbol/NR\" title=\"Newpark Resources Inc.\">NR</a> <font color=\"green\">+2.7%</font>.</li>\n<li>\n<b>After-hours top losers:</b> <a href=\"https://seekingalpha.com/symbol/GCAP\" title=\"GAIN Capital Holdings, Inc.\">GCAP</a> <font color=\"red\">-8.9%</font>. <a href=\"https://seekingalpha.com/symbol/NSH\" title=\"NuStar GP Holdings, LLC\">NSH</a> <font color=\"red\">-4.1%</font>. <a href=\"https://seekingalpha.com/symbol/JBL\" title=\"Jabil Inc.\">JBL</a> <font color=\"red\">-3.7%</font>. <a href=\"https://seekingalpha.com/symbol/WPRT\" title=\"Westport Fuel Systems, Inc.\">WPRT</a> <font color=\"red\">-3.6%</font>. PSDV <font color=\"red\">-3.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299512\" data-linked=\"After-hours top gainers / Losers, as of 5:15 p.m\" data-tweet=\"$HGEN $BBBY $AEPI - After-hours top gainers / Losers, as of 5:15 p.m https://seekingalpha.com/news/1299512-after-hours-top-gainers-losers-as-of-5-15-p-m?source=tweet\" data-url=\"https://seekingalpha.com/news/1299512-after-hours-top-gainers-losers-as-of-5-15-p-m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299492\" data-ts=\"1380143659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299492-bed-bath-and-beyond-plus-4_6-percent-ah-after-strong-earnings-sales-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond +4.6% AH after strong earnings, sales gains</a></h4><ul>     <li>Bed Bath &amp;&nbsp;Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) <font color='green'>+4.6%</font> AH after <a href=\"https://seekingalpha.com/currents/post/1299322\" target=\"_blank\">FQ2 earnings</a> rose 11% on a 9% jump in sales, both increases at the upper end of company guidance.</li>     <li>BBBY also raised the lower end of its full-year earnings estimate by $0.04/share, now seeing EPS of $4.88-$5.01; forecasts FQ3 EPS of $1.11-$1.16 vs. $1.12 analyst consensus and FQ4 outlook of $1.70-$1.77 EPS vs. $1.83 consensus.</li>     <li>FQ2 comp store sales rose ~3.7% vs. a ~3.5% increase in the year-ago quarter.</li>     <li>Gross margin narrowed to 39.4% from 39.8%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299492\" data-linked=\"Bed Bath &amp; Beyond +4.6% AH after strong earnings, sales gains\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond +4.6% AH after strong earnings, sales gains https://seekingalpha.com/news/1299492-bed-bath-and-beyond-plus-4_6-percent-ah-after-strong-earnings-sales-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/1299492-bed-bath-and-beyond-plus-4_6-percent-ah-after-strong-earnings-sales-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299392\" data-ts=\"1380141850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299392-blackberry-closes-near-8-two-pension-funds-only-want-pieces\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry closes near $8, two pension funds only want pieces</a></h4><ul>\n<li>With investor/analyst <a href=\"https://seekingalpha.com/currents/post/1298272\" target=\"_blank\">skepticism</a> about deal financing <a href=\"http://www.marketwatch.com/story/blackberry-slips-analyst-doubts-fairfax-deal-2013-09-25\" target=\"_blank\">easy to find,</a> BlackBerry (BBRY <font color=\"red\">-6.3%</font>) closed today below where it traded before the Fairfax deal was announced on Monday.</li>\n<li>The <em><a href=\"http://www.thestar.com/business/tech_news/2013/09/25/ottp_and_alberta_pension_fund_in_talks_with_fairfax_for_blackberry_assets_sources.html?utm_source=twitterfeed&amp;utm_medium=twitter\" target=\"_blank\">Toronto Star</a></em> reports BlackBerry's talks with two Canadian pension funds - the Ontario Teachers' Pension Plan and Alberta Investment Management - have stalled because the funds are only interested in certain assets, such as BlackBerry's network operations centers (IBM was <a href=\"https://seekingalpha.com/currents/post/480331\" target=\"_blank\">once reportedly interested </a>in them).</li>\n<li>\n<em>The Globe &amp; Mail</em> <a href=\"https://seekingalpha.com/currents/post/1298402\" target=\"_blank\">reported earlier today</a> the Ontario Teachers' Pension Plan was the only pension fund to show serious interest in BlackBerry after being courted by Prem Watsa.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1299392\" data-linked=\"BlackBerry closes near $8, two pension funds only want pieces\" data-tweet=\"$BB - BlackBerry closes near $8, two pension funds only want pieces https://seekingalpha.com/news/1299392-blackberry-closes-near-8-two-pension-funds-only-want-pieces?source=tweet\" data-url=\"https://seekingalpha.com/news/1299392-blackberry-closes-near-8-two-pension-funds-only-want-pieces\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299382\" data-ts=\"1380141393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDRO-OLD\" target=\"_blank\">NDRO-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299382-enduro-announces-11_2m-unit-offering-trust-minus-4-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enduro announces 11.2M-unit offering, Trust -4% AH</a></h4><ul>     <li>Enduro Royalty Trust (NYSE:<a href=\"https://seekingalpha.com/symbol/NDRO-OLD\" title=\"Enduro Royalty Trust\">NDRO-OLD</a>) <font color=\"red\">-4%</font> AH after announcing a public offering of 11.2M trust units by parent Enduro Resource Partners.</li>     <li>Enduro says it intends to use the net proceeds from the sale to pay down debt.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299382\" data-linked=\"Enduro announces 11.2M-unit offering, Trust -4% AH\" data-tweet=\"$NDRO-OLD - Enduro announces 11.2M-unit offering, Trust -4% AH https://seekingalpha.com/news/1299382-enduro-announces-11_2m-unit-offering-trust-minus-4-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1299382-enduro-announces-11_2m-unit-offering-trust-minus-4-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299372\" data-ts=\"1380141203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBL\" target=\"_blank\">JBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299372-jabil-issues-light-guidance-expects-35m-85m-blackberry-charge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jabil issues light guidance, expects $35M-$85M BlackBerry charge</a></h4><ul>     <li>Jabil (NYSE:<a href=\"https://seekingalpha.com/symbol/JBL\" title=\"Jabil Inc.\">JBL</a>) expects FQ1 revenue of $4.35B-$4.65B and EPS of $0.50-$0.60, below a consensus of $4.84B and $0.63.</li>     <li>While Diversified Manufacturing Services (44% of FQ4 revenue, sales +9% Y/Y) are expected to see 7% Y/Y growth in FQ1, Enterprise &amp; Infrastructure (29% of revenue, sales +9%) is expected to be flat, and High Velocity Services (27% of revenue, sales +1%) is expected to drop 25% (thanks in no small part to <a href=\"https://seekingalpha.com/currents/post/1292342\" target=\"_blank\">BlackBerry</a>).</li>     <li>Jabil adds it expects to record a $35M-$85M FY14 charge related to \"ongoing discussions with BlackBerry.\"</li>     <li>FQ4 gross margin was 7.3%, unchanged Y/Y.</li>     <li>Shares <font color=\"red\">-5.4%</font> AH. CC getting started (<a href=\"http://jbl.client.shareholder.com/eventdetail.cfm?eventid=122682\" target=\"_blank\">webcast</a>).</li>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1299232\" target=\"_blank\">FQ4 results</a>, PR, <a href=\"http://files.shareholder.com/downloads/JBL/2702236417x0x693308/737da7fa-a8f2-4c0d-8e58-8e2f512a8ba3/Slide_Presentation_09252013.pdf\" target=\"_blank\">slides</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299372\" data-linked=\"Jabil issues light guidance, expects $35M-$85M BlackBerry charge\" data-tweet=\"$JBL - Jabil issues light guidance, expects $35M-$85M BlackBerry charge https://seekingalpha.com/news/1299372-jabil-issues-light-guidance-expects-35m-85m-blackberry-charge?source=tweet\" data-url=\"https://seekingalpha.com/news/1299372-jabil-issues-light-guidance-expects-35m-85m-blackberry-charge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299342\" data-ts=\"1380140844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPRT\" target=\"_blank\">WPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299342-westport-minus-3_8-percent-ah-on-news-of-6m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westport -3.8% AH on news of 6M-share offering</a></h4><ul>     <li>Westport Innovations (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WPRT\" title=\"Westport Fuel Systems, Inc.\">WPRT</a>) <font color=\"red\">-3.8%</font> AH after announcing a 6M-share offering of common stock pursuant to a preliminary prospectus  supplement to its base shelf prospectus of June 20, 2013.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299342\" data-linked=\"Westport -3.8% AH on news of 6M-share offering\" data-tweet=\"$WPRT - Westport -3.8% AH on news of 6M-share offering https://seekingalpha.com/news/1299342-westport-minus-3_8-percent-ah-on-news-of-6m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1299342-westport-minus-3_8-percent-ah-on-news-of-6m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299332\" data-ts=\"1380140679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGS\" target=\"_blank\">PRGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299332-progress-software-beats-by-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progress Software beats by $0.03, beats on revenue</a></h4><ul>     <li>Progress Software (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PRGS\" title=\"Progress Software Corporation\">PRGS</a>): FQ3 EPS of $0.27 <font color=\"green\">beats by $0.03</font>.</li>\n<li>Revenue of $77.6M <font color=\"green\">beats by $0.9M</font>. Shares  <font color=\"green\">+2.36%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299332\" data-linked=\"Progress Software beats by $0.03, beats on revenue\" data-tweet=\"$PRGS - Progress Software beats by $0.03, beats on revenue https://seekingalpha.com/news/1299332-progress-software-beats-by-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1299332-progress-software-beats-by-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299322\" data-ts=\"1380140451\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299322-bed-bath-and-beyond-beats-by-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond beats by $0.01, beats on revenue</a></h4><ul>     <li>Bed Bath &amp; Beyond (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BBBY\" title=\"Bed Bath &amp; Beyond Inc.\">BBBY</a>): Q2 EPS of $1.16 <font color=\"green\">beats by $0.01</font>.</li>\n<li>Revenue of $2.82B <font color=\"green\">beats by $0.01B</font>. Shares  <font color=\"green\">+2.14%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299322\" data-linked=\"Bed Bath &amp; Beyond beats by $0.01, beats on revenue\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond beats by $0.01, beats on revenue https://seekingalpha.com/news/1299322-bed-bath-and-beyond-beats-by-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1299322-bed-bath-and-beyond-beats-by-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299302\" data-ts=\"1380140230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTK\" target=\"_blank\">PRTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299302-transcept-rejects-retrophin-proposal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transcept rejects Retrophin proposal</a></h4><ul>     <li>Transcept Pharmaceuticals (TSPT) formally rejects Retrophin's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RTRX\" title=\"Retrophin, Inc.\">RTRX</a>) $4/share takeout bid. <br>     </li>     <li>TSPT says the deal \"is not in the best interest of shareholders.\" (PR)</li>     <li>The company previously <a href=\"https://seekingalpha.com/currents/post/1287382\" target=\"_blank\">rejected a lower offer</a> from Retrophin.</li>     <li>TSPT <font color=\"green\">+5%</font> AH</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299302\" data-linked=\"Transcept rejects Retrophin proposal\" data-tweet=\"$PRTK $PRTK $RTRX - Transcept rejects Retrophin proposal https://seekingalpha.com/news/1299302-transcept-rejects-retrophin-proposal?source=tweet\" data-url=\"https://seekingalpha.com/news/1299302-transcept-rejects-retrophin-proposal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299272\" data-ts=\"1380139868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYK\" target=\"_blank\">SYK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299272-hansen-medical-rises-with-other-medical-robotics-names-after-mako-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hansen Medical rises with other medical robotics names after Mako deal</a></h4><ul>     <li>Also getting a boost Wednesday from the Stryker-Mako (<a href=\"https://seekingalpha.com/symbol/SYK\" title=\"Stryker Corporation\">SYK</a>, <a href=\"https://seekingalpha.com/symbol/MAKO\" title=\"MAKO Surgical Corp.\">MAKO</a>) deal was Hansen Medical (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HNSN\" title=\"Hansen Medical, Inc.\">HNSN</a>) which posted double-digit gains (<font color=\"green\">+14%</font>) for the session.</li>     <li>Intuitive Surgical (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ISRG\" title=\"Intuitive Surgical, Inc.\">ISRG</a>) and Accuray (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARAY\" title=\"Accuray Incorporated\">ARAY</a>) finished the day higher by <font color=\"green\">1%</font> and <font color=\"green\">1.9%</font> respectively.</li>     <li>Meanwhile, commentary continues to come in regarding the seemingly high price SYK paid in the deal.  BMO's Joanne Wuensch says that despite the lofty premium, \"it <a href=\"http://www.bloomberg.com/news/2013-09-25/stryker-to-buy-mako-for-1-65-billion-for-robotic-surgery-1-.html\" target=\"_blank\">makes a lot of sense</a> [as] SYK takes a step forward into robotic surgery and consolidates its orthopedic silo.\"</li>     <li>Previous coverage <a href=\"https://seekingalpha.com/currents/search?query=mako+stryker\" target=\"_blank\">here</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299272\" data-linked=\"Hansen Medical rises with other medical robotics names after Mako deal\" data-tweet=\"$SYK $SYK $MAKO - Hansen Medical rises with other medical robotics names after Mako deal https://seekingalpha.com/news/1299272-hansen-medical-rises-with-other-medical-robotics-names-after-mako-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1299272-hansen-medical-rises-with-other-medical-robotics-names-after-mako-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299232\" data-ts=\"1380139529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBL\" target=\"_blank\">JBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299232-jabil-circuit-beats-by-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jabil Circuit beats by $0.02, beats on revenue</a></h4><ul>     <li>Jabil Circuit (NYSE:<a href=\"https://seekingalpha.com/symbol/JBL\" title=\"Jabil Inc.\">JBL</a>): FQ4 EPS of $0.56 <font color=\"green\">beats by $0.02</font>.</li>\n<li>Revenue of $4.8B <font color=\"green\">beats by $0.29B</font>. Shares  <font color=\"red\">-3.67%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299232\" data-linked=\"Jabil Circuit beats by $0.02, beats on revenue\" data-tweet=\"$JBL - Jabil Circuit beats by $0.02, beats on revenue https://seekingalpha.com/news/1299232-jabil-circuit-beats-by-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1299232-jabil-circuit-beats-by-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299212\" data-ts=\"1380139135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299212-petrobras-would-consider-re-opening-refinery-partnership-with-pdvsa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras would consider re-opening refinery partnership with PdVSA</a></h4><ul>     <li>Petrobras (<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petrobras - Petroleo Brasileiro S.A.\">PBR</a> <font color=\"red\">-1.7%</font>) <a href=\"http://online.wsj.com/article/BT-CO-20130925-706756.html\" target=\"_blank\">would still welcome</a> Venezuela's PdVSA participation in the $17B Abreu e Lima refinery project - provided it cuts a check for ~$6.8B to cover its original 40% stake in the planned joint venture - CEO Maria das Gracas says.</li>     <li>PBR has been building the refinery, which is 80% complete, on its own after PdVSA repeatedly missed deadlines to provide cash and loan guarantees to cover its part of construction costs.</li>\n<li>The <em>Valor Economico</em> newspaper reported yesterday that PBR planned to pull the plug on the joint venture on Nov. 1.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299212\" data-linked=\"Petrobras would consider re-opening refinery partnership with PdVSA\" data-tweet=\"$PBR - Petrobras would consider re-opening refinery partnership with PdVSA https://seekingalpha.com/news/1299212-petrobras-would-consider-re-opening-refinery-partnership-with-pdvsa?source=tweet\" data-url=\"https://seekingalpha.com/news/1299212-petrobras-would-consider-re-opening-refinery-partnership-with-pdvsa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299202\" data-ts=\"1380139040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299202-reuters-nokia-thinking-about-approaching-alcatel-regarding-tie-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Nokia thinking about approaching Alcatel regarding tie-up</a></h4><ul>\n<li>\n<a href=\"http://www.reuters.com/article/2013/09/25/us-nokia-alcatellucent-idUSBRE98O11G20130925\" target=\"_blank\">Several sources tell Reuters</a> Nokia (<a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a> <font color=\"green\">+0.8%</font>) is \"discussing internally\" whether it should approach Alcatel-Lucent (ALU <font color=\"green\">+4.6%</font>) about a tie-up. The news service isn't clear on whether Nokia is interested in a full-blown merger. Sources caution no formal talks are currently underway.</li>\n<li>Alcatel shares have jumped on the report. They took off <a href=\"https://seekingalpha.com/currents/post/1255922\" target=\"_blank\">earlier this month</a> after the Nokia-Microsoft deal fueled M&amp;A speculation. The Microsoft deal stands to leave Nokia with nearly $20B in total cash, and over $10B in net cash, to go shopping with.</li>\n<li>Once the Microsoft deal closes, Nokia will be focused on telecom infrastructure (via NSN), mapping/location services, and IP licensing. One Reuters source states Nokia held \"on again, off again\" talks about buying Alcatel's mobile infrastructure business until late 2012.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1299202\" data-linked=\"Reuters: Nokia thinking about approaching Alcatel regarding tie-up\" data-tweet=\"$NOK - Reuters: Nokia thinking about approaching Alcatel regarding tie-up https://seekingalpha.com/news/1299202-reuters-nokia-thinking-about-approaching-alcatel-regarding-tie-up?source=tweet\" data-url=\"https://seekingalpha.com/news/1299202-reuters-nokia-thinking-about-approaching-alcatel-regarding-tie-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299192\" data-ts=\"1380138632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAG\" target=\"_blank\">AMAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299192-amag-pharmaceuticals-plunges-as-fda-identifies-deficiencies-in-snda\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMAG Pharmaceuticals plunges as FDA identifies deficiencies in sNDA</a></h4><ul>\n<li>AMAG Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/AMAG\" title=\"AMAG Pharmaceuticals, Inc.\">AMAG</a> <font color=\"red\">-13.4%</font>) slumps, falling double-digits on heavy volume.</li>\n<li>In an SEC filing, the company says the FDA \"has identified deficiencies that preclude discussion of labeling and postmarketing requirements/commitments\" for the company's iron deficiency anemia treatment Feraheme. (<a href=\"http://www.sec.gov/Archives/edgar/data/792977/000110465913071972/a13-21251_18k.htm\" target=\"_blank\">8-K</a>)</li>\n<li>It isn't entirely clear what this means, but investors should note that the company has a PDUFA date on October 21 for its sNDA.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1299192\" data-linked=\"AMAG Pharmaceuticals plunges as FDA identifies deficiencies in sNDA\" data-tweet=\"$AMAG - AMAG Pharmaceuticals plunges as FDA identifies deficiencies in sNDA https://seekingalpha.com/news/1299192-amag-pharmaceuticals-plunges-as-fda-identifies-deficiencies-in-snda?source=tweet\" data-url=\"https://seekingalpha.com/news/1299192-amag-pharmaceuticals-plunges-as-fda-identifies-deficiencies-in-snda\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299162\" data-ts=\"1380136930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARIA\" target=\"_blank\">ARIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299162-ariad-slumps-as-clovis-finds-no-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ariad slumps as Clovis finds no interest</a></h4><ul><li>Ariad Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ARIA' title='ARIAD Pharmaceuticals, Inc.'>ARIA</a> <font color='red'>-3.6%</font>)&nbsp;began the day in the red and has traded steadily lower throughout the session.</li><li>Perhaps weighing on the shares is the news that Clovis Oncology (<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color='red'>-11.1%</font>)&nbsp;has received <a href=\"https://seekingalpha.com/currents/post/1297322\" target=\"_blank\">no interest from buyers</a> after hiring Credit Suisse to explore strategic options.</li><li>Like CLVS' lead compound CO-1686, ARIA's <a href=\"https://seekingalpha.com/currents/search?query=AP26113\" target=\"_blank\">AP26113</a> is       an EGFR inhibitor. <br></li><li>When news hit last week that CLVS was pursuing a sale, <a href=\"https://seekingalpha.com/currents/post/1284532\" target=\"_blank\">ARIA spiked</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1299162\" data-linked=\"Ariad slumps as Clovis finds no interest\" data-tweet=\"$ARIA $ARIA $CLVS - Ariad slumps as Clovis finds no interest https://seekingalpha.com/news/1299162-ariad-slumps-as-clovis-finds-no-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/1299162-ariad-slumps-as-clovis-finds-no-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299122\" data-ts=\"1380136095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABT\" target=\"_blank\">ABT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299122-abbot-laboratories-slides-after-bloomberg-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abbot Laboratories slides after Bloomberg mention</a></h4><ul>\n<li>Abbott Laboratories (<a href=\"https://seekingalpha.com/symbol/ABT\" title=\"Abbott Laboratories\">ABT</a> <font color=\"red\">-2.1%</font>) suffers through a lackluster session.</li>\n<li>Investors may be reacting to a Bloomberg piece which discusses <a href=\"http://www.bloomberg.com/news/2013-09-24/medical-device-makers-see-eu-rules-slowing-u-s-approvals.html\" target=\"_blank\">tougher rules for medical device approvals</a> in Europe.</li>\n<li>According to the article, \"smaller U.S. companies depend on the EU\u2019s easier process to test their products and accumulate patient data that they may use to get approval in the U.S.\"</li>\n<li>Although ABT is certainly not small, its MitraClip clamp is mentioned as an example of a product that is marketed in Europe but is still awaiting FDA approval. One factor ABT hopes will sway the FDA: The product's performance overseas.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1299122\" data-linked=\"Abbot Laboratories slides after Bloomberg mention\" data-tweet=\"$ABT - Abbot Laboratories slides after Bloomberg mention https://seekingalpha.com/news/1299122-abbot-laboratories-slides-after-bloomberg-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/1299122-abbot-laboratories-slides-after-bloomberg-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299112\" data-ts=\"1380136080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNW\" target=\"_blank\">GNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299112-genworth-looks-to-boost-long-term-care-profits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genworth looks to boost long-term care profits</a></h4><ul>\n<li>Genworth (<a href=\"https://seekingalpha.com/symbol/GNW\" title=\"Genworth Financial, Inc.\">GNW</a> <font color=\"green\">+3.5%</font>) continues a nice two-day run after last night announcing its intention to seek rate increases on certain Privileged Choice and Classic Select policies sold over the last 10 years. The premium boosts requested will range from 6-13% on more than $800M in annual in-force premiums, and are expected to offset lower-than-expected returns caused by improvements in life expectancy and lower-than-expected lapse rates.</li>\n<li>Presenting at KBW today (<a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=175970&amp;p=irol-presentations\" target=\"_blank\">webcast</a>), CEO Tom McInerney says an IPO of Genworth's Australian mortgage unit will<a href=\"http://www.bloomberg.com/news/2013-09-25/genworth-says-australia-unit-ipo-more-likely-next-year.html\" target=\"_blank\"> likely come in 2014</a> as opposed to this year, due to \"regulatory uncertainty.\" Genworth previously had attempted and failed to IPO the unit in 2012.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1299112\" data-linked=\"Genworth looks to boost long-term care profits\" data-tweet=\"$GNW - Genworth looks to boost long-term care profits https://seekingalpha.com/news/1299112-genworth-looks-to-boost-long-term-care-profits?source=tweet\" data-url=\"https://seekingalpha.com/news/1299112-genworth-looks-to-boost-long-term-care-profits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299062\" data-ts=\"1380134885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPHT\" target=\"_blank\">OPHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299062-opthotech-soars-in-debut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Opthotech soars in debut</a></h4><ul>     <li>More from the world of <a href=\"https://seekingalpha.com/currents/post/1298742\" target=\"_blank\">healthcare-related</a> IPOs:&nbsp;Opthotech (<a href='https://seekingalpha.com/symbol/OPHT' title='Ophthotech Corporation'>OPHT</a> <font color='green'>+18%</font>) &mdash; they make Fovista, the Phase 3 wet AMD therapy &mdash; opens at $23.06 and moves higher.</li>     <li>Fovista is being developed as a combo treatment for use with anti-VEGF agents like Macugen (VRX), and <a href=\"https://seekingalpha.com/currents/search?query=lucentis\" target=\"_blank\">Lucentis</a> (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a>, <a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299062\" data-linked=\"Opthotech soars in debut\" data-tweet=\"$OPHT $ISEE $BHC - Opthotech soars in debut https://seekingalpha.com/news/1299062-opthotech-soars-in-debut?source=tweet\" data-url=\"https://seekingalpha.com/news/1299062-opthotech-soars-in-debut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299052\" data-ts=\"1380134743\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JASO\" target=\"_blank\">JASO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299052-solar-stocks-add-to-2013-gains-after-tariff-proposal-aired\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solar stocks add to 2013 gains after tariff proposal aired</a></h4><ul>     <li>U.S. solar trade group SEIA <a href=\"https://seekingalpha.com/article/1713012-trade-group-offers-compromise-for-u-s-china-solar-spat\" target=\"_blank\">has issued a proposal</a> that aims to remove the anti-dumping tariffs <a href=\"https://seekingalpha.com/currents/post/650521\" target=\"_blank\">imposed last year</a> by the ITC on Chinese solar module imports, and also put an end to China's threats to issue retaliatory tariffs on U.S. polysilicon imports.</li>     <li>The SEIA proposes Chinese manufacturers establish a fund to compensate U.S. rivals for losses caused by Chinese state subsidies, and that mechanisms be created to protect U.S. firms from having to deal with a flood of Chinese imports.</li>     <li>Both Chinese and U.S. solar names seem to be responding well. <a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a> <font color=\"green\">+8.6%</font>. <a href=\"https://seekingalpha.com/symbol/SOL\" title=\"ReneSola Ltd.\">SOL</a> <font color=\"green\">+8.4%</font>. <a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"green\">+8.2%</font>. SUNE <font color=\"green\">+6.3%</font> (<a href=\"https://seekingalpha.com/currents/post/1297202\" target=\"_blank\">previous</a>). <a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a> <font color=\"green\">+5.9%</font>. <a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a> <font color=\"green\">+5.5%</font>. <a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a> <font color=\"green\">+4.2%</font>. <a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a> <font color=\"green\">+5.8%</font>. <a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a> <font color=\"green\">+5.9%</font>. <a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a> <font color=\"green\">+3.3%</font>.</li>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1191312\" target=\"_blank\">China and the EU</a> reached a solar anti-dumping settlement in August.</li>     <li>Solar ETFs: <a href=\"https://seekingalpha.com/symbol/KWT\" title=\"VanEck Vectors Solar Energy ETF\">KWT</a>, <a href=\"https://seekingalpha.com/symbol/TAN\" title=\"Invesco Solar Portfolio ETF\">TAN</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299052\" data-linked=\"Solar stocks add to 2013 gains after tariff proposal aired\" data-tweet=\"$JASO $JASO $SOL - Solar stocks add to 2013 gains after tariff proposal aired https://seekingalpha.com/news/1299052-solar-stocks-add-to-2013-gains-after-tariff-proposal-aired?source=tweet\" data-url=\"https://seekingalpha.com/news/1299052-solar-stocks-add-to-2013-gains-after-tariff-proposal-aired\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1299042\" data-ts=\"1380134440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCJ\" target=\"_blank\">CCJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1299042-cameco-in-tax-dispute-accused-of-offshoring-profits-in-switzerland\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cameco in tax dispute, accused of offshoring profits in Switzerland</a></h4><ul>     <li>Cameco (<a href=\"https://seekingalpha.com/symbol/CCJ\" title=\"Cameco Corporation\">CCJ</a> <font color=\"red\">-1.5%</font>) has <a href=\"http://business.financialpost.com/2013/09/25/cameco-cra-tax/\" target=\"_blank\">avoided paying hundreds of millions of dollars</a> in Canadian taxes by setting up a subsidiary in Switzerland, the Canada Revenue Agency says.</li>     <li>At issue is a deal CCJ made in 1999 - when uranium prices were much lower - to sell uranium to its wholly-owned Swiss subsidiary; the allegation is that the subsidiary then sold the uranium for more and recorded the profits in Switzerland, where taxes are lower.</li>     <li>CCJ says it hasn't done anything wrong and estimates it could end up owing as much as $850M in Canadian corporate taxes if it loses the case.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1299042\" data-linked=\"Cameco in tax dispute, accused of offshoring profits in Switzerland\" data-tweet=\"$CCJ - Cameco in tax dispute, accused of offshoring profits in Switzerland https://seekingalpha.com/news/1299042-cameco-in-tax-dispute-accused-of-offshoring-profits-in-switzerland?source=tweet\" data-url=\"https://seekingalpha.com/news/1299042-cameco-in-tax-dispute-accused-of-offshoring-profits-in-switzerland\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298942\" data-ts=\"1380132005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAX\" target=\"_blank\">BAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298942-baxter-slides-on-jpmorgan-hemophilia-comments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baxter slides on JPMorgan hemophilia comments</a></h4><ul>\n<li>Shares of Baxter (<a href=\"https://seekingalpha.com/symbol/BAX\" title=\"Baxter International Inc\">BAX</a> <font color=\"red\">-6.1%</font>) trade notably lower on heavy volume after a JPMorgan <a href=\"http://www.streetinsider.com/New+Coverage/JPMorgan+Starts+Baxter+International+%28BAX%29+at+Neutral/8718806.html\" target=\"_blank\">initiation</a> at Neutral.</li>\n<li>Citing a survey of \"50 hematologists caring for more than 15% of the U.S. market,\" JPM says the hemophilia drug space is set to get <a href=\"http://online.wsj.com/article/BT-CO-20130925-708969.html\" target=\"_blank\">more competitive</a>.</li>\n<li>More patients may begin switching to long-lasting clotting factor therapies like Biogen's (<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"red\">-0.2%</font>) <a href=\"https://seekingalpha.com/currents/search?query=eloctate\" target=\"_blank\">Eloctate</a>. </li>\n<li>Price target is $76.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298942\" data-linked=\"Baxter slides on JPMorgan hemophilia comments\" data-tweet=\"$BAX $BAX $BIIB - Baxter slides on JPMorgan hemophilia comments https://seekingalpha.com/news/1298942-baxter-slides-on-jpmorgan-hemophilia-comments?source=tweet\" data-url=\"https://seekingalpha.com/news/1298942-baxter-slides-on-jpmorgan-hemophilia-comments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298932\" data-ts=\"1380131944\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298932-wal-mart-drags-major-averages-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wal-Mart drags major averages down</a></h4><ul>\n<li>Wal-Mart's quick tumble as it <a href=\"https://seekingalpha.com/currents/post/1298912\" target=\"_blank\">reportedly cuts orders</a> due to high inventories is hitting the major averages, with the Dow (<a href=\"https://seekingalpha.com/symbol/dia\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a> <font color=\"red\">-0.3%</font>) and S&amp;P 500 (<a href=\"https://seekingalpha.com/symbol/spy\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a> <font color=\"red\">-0.2%</font>) giving up small gains to move into the red, and the Nasdaq 100 (<a href=\"https://seekingalpha.com/symbol/qqq\" title=\"PowerShares QQQ Trust ETF\">QQQ</a> <font color=\"red\">-0.2%</font>) coming along as well.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/ivv\" title=\"iShares Core S&amp;P 500 ETF\">IVV</a>, <a href=\"https://seekingalpha.com/symbol/spy\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a>, <a href=\"https://seekingalpha.com/symbol/voo\" title=\"Vanguard S&amp;P 500 ETF\">VOO</a>, <a href=\"https://seekingalpha.com/symbol/rwl\" title=\"RevenueShares Large Cap ETF\">RWL</a>, <a href=\"https://seekingalpha.com/symbol/sfla\" title=\"iPath Long Extended 3x S&amp;P 500 Index TR Index ETN\">SFLA</a>, <a href=\"https://seekingalpha.com/symbol/sso\" title=\"ProShares Ultra S&amp;P 500 ETF\">SSO</a>, <a href=\"https://seekingalpha.com/symbol/upro\" title=\"ProShares UltraPro S&amp;P 500 ETF\">UPRO</a>, <a href=\"https://seekingalpha.com/symbol/sds\" title=\"ProShares UltraShort S&amp;P 500 ETF\">SDS</a>, <a href=\"https://seekingalpha.com/symbol/spxu\" title=\"ProShares UltraPro Short S&amp;P 500 ETF\">SPXU</a>, <a href=\"https://seekingalpha.com/symbol/sh\" title=\"ProShares Short S&amp;P 500 ETF\">SH</a>, <a href=\"https://seekingalpha.com/symbol/eps\" title=\"WisdomTree Earnings 500 ETF\">EPS</a>, <a href=\"https://seekingalpha.com/symbol/rsp\" title=\"Guggenheim S&amp;P Equal Weight ETF\">RSP</a>, <a href=\"https://seekingalpha.com/symbol/bxub\" title=\"Barclays Capital Long B Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUB</a>, <a href=\"https://seekingalpha.com/symbol/bxuc\" title=\"Barclays Capital Long C Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUC</a>, <a href=\"https://seekingalpha.com/symbol/bxdb\" title=\"Barclays Capital Short B Leveraged Exchange Traded Notes Linked to the Inverse Performance of the S&amp;P 500® Total Return Index\">BXDB</a>, <a href=\"https://seekingalpha.com/symbol/dia\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a>, <a href=\"https://seekingalpha.com/symbol/ddm\" title=\"ProShares Ultra Dow 30 ETF\">DDM</a>, <a href=\"https://seekingalpha.com/symbol/udow\" title=\"ProShares UltraPro Dow 30 ETF\">UDOW</a>, <a href=\"https://seekingalpha.com/symbol/dxd\" title=\"ProShares UltraShort Dow30 ETF\">DXD</a>, <a href=\"https://seekingalpha.com/symbol/sdow\" title=\"ProShares UltraPro Short Dow 30 ETF\">SDOW</a>, <a href=\"https://seekingalpha.com/symbol/dog\" title=\"ProShares Short Dow 30 ETF\">DOG</a>, <a href=\"https://seekingalpha.com/symbol/qqq\" title=\"PowerShares QQQ Trust ETF\">QQQ</a>, <a href=\"https://seekingalpha.com/symbol/qqew\" title=\"First Trust NASDAQ-100 Equal Weight Index ETF\">QQEW</a>, <a href=\"https://seekingalpha.com/symbol/tqqq\" title=\"ProShares UltraPro QQQ ETF\">TQQQ</a>, <a href=\"https://seekingalpha.com/symbol/qid\" title=\"ProShares UltraShort QQQ ETF\">QID</a>, <a href=\"https://seekingalpha.com/symbol/sqqq\" title=\"ProShares UltraPro Short QQQ ETF\">SQQQ</a>, <a href=\"https://seekingalpha.com/symbol/psq\" title=\"ProShares Short QQQ ETF\">PSQ</a>, <a href=\"https://seekingalpha.com/symbol/qld\" title=\"ProShares Ultra QQQ ETF\">QLD</a>, <a href=\"https://seekingalpha.com/symbol/qqqe\" title=\"Direxion NASDAQ-100 Equal Weighted Index Shares ETF\">QQQE</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298932\" data-linked=\"Wal-Mart drags major averages down\" data-tweet=\"$DIA $SPY $QQQ - Wal-Mart drags major averages down https://seekingalpha.com/news/1298932-wal-mart-drags-major-averages-down?source=tweet\" data-url=\"https://seekingalpha.com/news/1298932-wal-mart-drags-major-averages-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298912\" data-ts=\"1380131374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMT\" target=\"_blank\">WMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298912-report-wal-mart-cutting-orders-on-inventory-backlog\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Wal-Mart cutting orders on inventory backlog</a></h4><ul> <li>Wal-Mart (<a href=\"https://seekingalpha.com/symbol/WMT\" title=\"Walmart Inc.\">WMT</a> <font color=\"red\">-2%</font>) is <a href=\"http://www.cnbc.com/id/101054759\" target=\"_blank\">cutting orders</a> due to an inventory backlog, according to report quoting an ordering manager at the retailer's Arkansas headquarters.</li> <li>Shares of Wal-Mart and a number of other retailers are having a bit of a panic attack as details are being sorted out.</li> <li>Decliners: <a href=\"https://seekingalpha.com/symbol/PSMT\" title=\"PriceSmart, Inc.\">PSMT</a> <font color=\"red\">-1.7%</font>, <a href=\"https://seekingalpha.com/symbol/COST\" title=\"Costco Wholesale Corporation\">COST</a> <font color=\"red\">-1.1%</font>, <a href=\"https://seekingalpha.com/symbol/TGT\" title=\"Target Corporation\">TGT</a> <font color=\"red\">-1.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298912\" data-linked=\"Report: Wal-Mart cutting orders on inventory backlog\" data-tweet=\"$WMT $WMT $PSMT - Report: Wal-Mart cutting orders on inventory backlog https://seekingalpha.com/news/1298912-report-wal-mart-cutting-orders-on-inventory-backlog?source=tweet\" data-url=\"https://seekingalpha.com/news/1298912-report-wal-mart-cutting-orders-on-inventory-backlog\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298902\" data-ts=\"1380130343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DQ\" target=\"_blank\">DQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298902-daqo-issues-statement-gives-back-some-of-yesterdays-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daqo issues statement, gives back some of yesterday&#39;s gains</a></h4><ul>     <li>After <font color=\"green\">soaring 61%</font> yesterday in the absence of major news, Daqo (<a href=\"https://seekingalpha.com/symbol/DQ\" title=\"DAQO New Energy Corp.\">DQ</a> <font color=\"red\">-17.4%</font>) is giving back a chunk of its gains today.</li>     <li>This morning, the Chinese polysilicon maker issued a boilerplate PR stating it isn't company policy \"to comment on unusual market activity or speculative matters.\"</li>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1296532\" target=\"_blank\">Yesterday:</a> Daqo flies higher</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298902\" data-linked=\"Daqo issues statement, gives back some of yesterday&#39;s gains\" data-tweet=\"$DQ - Daqo issues statement, gives back some of yesterday&#39;s gains https://seekingalpha.com/news/1298902-daqo-issues-statement-gives-back-some-of-yesterdays-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/1298902-daqo-issues-statement-gives-back-some-of-yesterdays-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298892\" data-ts=\"1380129919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TI\" target=\"_blank\">TI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298892-telecom-italia-resists-pressure-to-sell-latin-ops-shares-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telecom Italia resists pressure to sell Latin ops, shares fall</a></h4><ul>\n<li>At a parliamentary hearing in Rome, Telecom Italia (<a href=\"https://seekingalpha.com/symbol/TI\" title=\"Telecom Italia S.P.A.\">TI</a> <font color=\"red\">-4.8%</font>) <a href=\"http://www.bloomberg.com/news/2013-09-24/brazil-phone-watchdog-said-to-prefer-tim-sale-to-breakup.html\" target=\"_blank\">reiterated his opposition</a> to a sale of the company's Brazilian and Argentine assets, at least over the near-term. Bernabe argued selling the units, responsible for 40% of TI's 2012 revenue, would hurt the carrier's international profile.</li>\n<li>TIM (<a href=\"https://seekingalpha.com/symbol/TSU\" title=\"TIM Participações S.A.\">TSU</a> <font color=\"red\">-4.8%</font>), TI's Brazilian unit, is joining TI in selling off after rallying yesterday. A downgrade to Hold from Stifel could be contributing to the losses. Telecom Argentina (<a href=\"https://seekingalpha.com/symbol/TEO\" title=\"Telecom Argentina S.A.\">TEO</a> <font color=\"green\">+0.3%</font>), in which TI owns an indirect 37% stake, is up slightly.</li>\n<li>Bernabe's remarks come a day after Telefonica (<a href=\"https://seekingalpha.com/symbol/TEF\" title=\"Telefonica S.A.\">TEF</a> <font color=\"green\">+0.8%</font>) <a href=\"https://seekingalpha.com/currents/post/1297032\" target=\"_blank\">announced a deal</a> that could let it eventually take full control of holding company Telco and its 22.4% TI stake. Telefonica, whose Brazilian unit (<a href=\"https://seekingalpha.com/symbol/VIV\" title=\"Telefonica Brasil, S.A\">VIV</a> <font color=\"red\">-2.9%</font>) competes with TIM, is widely believed to be pushing TI to sell TIM to shore up its balance sheet and appease regulator Anatel (<a href=\"https://seekingalpha.com/currents/post/1297082\" target=\"_blank\">previous</a>).</li>\n<li>Bloomberg reports Anatel would prefer TIM be sold in full rather than have its assets sold piecemeal. That could translate into a sale into a major foreign carrier such as Vodafone or AT&amp;T, which in turn would spell tougher competition for Telefonica and fellow Brazilian carriers Oi (OIBR <font color=\"red\">-9.6%</font>), America Movil (<a href=\"https://seekingalpha.com/symbol/AMX\" title=\"America Movil SA de CV\">AMX</a>), and NII Holdings (<a href=\"https://seekingalpha.com/symbol/NIHD\" title=\"NII Holdings, Inc.\">NIHD</a> <font color=\"green\">+1.1%</font>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298892\" data-linked=\"Telecom Italia resists pressure to sell Latin ops, shares fall\" data-tweet=\"$TI $TI $TSU - Telecom Italia resists pressure to sell Latin ops, shares fall https://seekingalpha.com/news/1298892-telecom-italia-resists-pressure-to-sell-latin-ops-shares-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/1298892-telecom-italia-resists-pressure-to-sell-latin-ops-shares-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298872\" data-ts=\"1380128655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PACB\" target=\"_blank\">PACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298872-pacific-biosciences-soars-59-percent-after-development-deal-with-roche\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Biosciences soars 59% after development deal with Roche</a></h4><ul>\n<li>Pacific Biosciences (<a href=\"https://seekingalpha.com/symbol/PACB\" title=\"Pacific Biosciences of California\">PACB</a> <font color=\"green\">+59%</font>) will receive $35M upfront and expects another $40M in funding tied to development milestones. Once development is completed, the company expects to receive further income from the manufacture and supply of products Roche (<a href=\"https://seekingalpha.com/symbol/RHHBY\" title=\"Roche Holding Ltd ADR\">OTCQX:RHHBY</a> <font color=\"green\">+0.9%</font>) will market.</li>\n<li>Roche: \"We see great potential in Pacific Biosciences' sequencing technology for the development of future clinical sequencing applications.\"</li>\n<li>PACB: \"We believe the combination of our SMRT Sequencing technology with Roche's market position and expertise in diagnostics will allow accelerated commercial success for both companies.\"</li>\n<li>Kudos to SA Pro's Stephen Simpson who <a href=\"https://seekingalpha.com/article/1510932-pacific-biosciences-will-go-checkers-or-wreckers\" target=\"_blank\">just 3 months ago</a> spotted Pacific Biosciences as a risky, but potentially explosive play at about half of today's price.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298872\" data-linked=\"Pacific Biosciences soars 59% after development deal with Roche\" data-tweet=\"$PACB $PACB $RHHBY - Pacific Biosciences soars 59% after development deal with Roche https://seekingalpha.com/news/1298872-pacific-biosciences-soars-59-percent-after-development-deal-with-roche?source=tweet\" data-url=\"https://seekingalpha.com/news/1298872-pacific-biosciences-soars-59-percent-after-development-deal-with-roche\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298832\" data-ts=\"1380127927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTWW\" target=\"_blank\">QTWW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298832-quantum-fuel-plus-20-percent-on-contract-for-cng-storage-tanks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quantum Fuel +20% on contract for CNG storage tanks</a></h4><ul>     <li>Quantum Fuel Systems (<a href=\"https://seekingalpha.com/symbol/QTWW\" title=\"Quantum Fuel Systems Technologies Worldwide, Inc.\">QTWW</a> <font color=\"green\">+20.9%</font>) powers higher after it is awarded a record $9.3M production contract for delivery of Q-Lite compressed natural gas storage tanks for heavy-duty truck applications.</li>\n<li>QTWW says it Q-Lite storage tank is specifically  designed and engineered for OEM-level truck applications and is the  lightest and most storage efficient large diameter tank on the market.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298832\" data-linked=\"Quantum Fuel +20% on contract for CNG storage tanks\" data-tweet=\"$QTWW - Quantum Fuel +20% on contract for CNG storage tanks https://seekingalpha.com/news/1298832-quantum-fuel-plus-20-percent-on-contract-for-cng-storage-tanks?source=tweet\" data-url=\"https://seekingalpha.com/news/1298832-quantum-fuel-plus-20-percent-on-contract-for-cng-storage-tanks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298822\" data-ts=\"1380127580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298822-midday-top-10-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers / Losers</a></h4><ul>     <li><b>Midday top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/MAKO' title='MAKO Surgical Corp.'>MAKO</a> <font color='green'>+82%</font>. <a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a> <font color='green'>+62%</font>. ONTY <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/QTWW' title='Quantum Fuel Systems Technologies Worldwide, Inc.'>QTWW</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/UNXL' title='Uni-Pixel, Inc.'>UNXL</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/FU' title='FAB Universal Corp.'>FU</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/HNSN' title='Hansen Medical, Inc.'>HNSN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/VRTB-OLD' title='Vestin Realty Mortgage II, Inc.'>VRTB</a> <font color='green'>+11%</font>.</li><li><b>Midday top 10 Losers:</b> <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/LLEN' title='L&L Energy, Inc.'>LLEN</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CRDS' title='Crossroads Systems, Inc.'>CRDS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CRRS' title='Corporate Resource Services, Inc.'>OTC:CRRS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp'>SHIP</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/AMAG' title='AMAG Pharmaceuticals, Inc.'>AMAG</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/GNVC' title='GenVec, Inc.'>GNVC</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/REE' title='Rare Element Resources Ltd.'>REE</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298822\" data-linked=\"Midday top 10 gainers / Losers\" data-tweet=\"$MAKO $PACB $CASC - Midday top 10 gainers / Losers https://seekingalpha.com/news/1298822-midday-top-10-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1298822-midday-top-10-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298802\" data-ts=\"1380126617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRP\" target=\"_blank\">CTRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298802-deutsches-ctrip-upgrade-mobile-strength-praised-checks-solid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche&#39;s Ctrip upgrade: Mobile strength praised, checks solid</a></h4><ul><li>Deutsche's <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/09/3941655/update-deutsche-bank-upgrades-ctrip-com-on-emerging-mark\" target=\"_blank\">Vivian Hao</a>, who <a href=\"https://seekingalpha.com/currents/post/1298212\" target=\"_blank\">upgraded</a> Ctrip (<a href='https://seekingalpha.com/symbol/CTRP' title='Ctrip.com International, Ltd.'>CTRP</a> <font color='green'>+7.7%</font>) to Buy this morning, declares the Chinese online travel agency is \"emerging as a clear leader in mobile.\" She also states checks point to \"strong travel booking volumes going into the peak 3Q season,\" with hotel volumes doing well thanks to mobile and Mid-Autumn Festival deals.</li><li>Mobile <a href=\"https://seekingalpha.com/currents/post/1185582\" target=\"_blank\">accounted for 20% and 15%</a> of Ctrip's hotel and air ticket bookings, respectively. Hotel reservation revenue (39% of total revenue) rose 25% Y/Y in the quarter, as 44% volume growth more than offset a 14% drop in commission/room.</li><li>Ctrip is making new highs. Smaller rival eLong (<a href='https://seekingalpha.com/symbol/LONG' title='eLong, Inc.'>LONG</a> <font color='green'>+1.3%</font>) is up slightly.</li></ul><div class=\"tiny-share-widget\" data-id=\"1298802\" data-linked=\"Deutsche&#39;s Ctrip upgrade: Mobile strength praised, checks solid\" data-tweet=\"$CTRP $TCOM $LONG - Deutsche&#39;s Ctrip upgrade: Mobile strength praised, checks solid https://seekingalpha.com/news/1298802-deutsches-ctrip-upgrade-mobile-strength-praised-checks-solid?source=tweet\" data-url=\"https://seekingalpha.com/news/1298802-deutsches-ctrip-upgrade-mobile-strength-praised-checks-solid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298782\" data-ts=\"1380125848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REE\" target=\"_blank\">REE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298782-rare-element-minus-10_5-percent-after-announcing-8m-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rare Element -10.5% after announcing $8M offering</a></h4><ul>     <li>Rare Element Resources (<a href=\"https://seekingalpha.com/symbol/REE\" title=\"Rare Element Resources Ltd.\">REE</a> <font color=\"red\">-10.5%</font>) shares swirl to their lowest of the day after announcing an $8M offering.</li>     <li>REE entered into a purchase agreement with investors agreeing to sell ~2.67M common shares and warrants to purchase up to ~1,33M shares; the price of each unit is $2.988, a 10% discount to yesterday's closing price.</li>     <li>Proceeds from the offering will be used to advance engineering and metallurgical work as well as permitting on the Bear Lodge project and for general corporate purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298782\" data-linked=\"Rare Element -10.5% after announcing $8M offering\" data-tweet=\"$REE - Rare Element -10.5% after announcing $8M offering https://seekingalpha.com/news/1298782-rare-element-minus-10_5-percent-after-announcing-8m-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1298782-rare-element-minus-10_5-percent-after-announcing-8m-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298742\" data-ts=\"1380125204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMI\" target=\"_blank\">FMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298742-foundation-medicine-soars-in-debut-evoke-underwhelms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foundation Medicine soars in debut, Evoke underwhelms</a></h4><ul>     <li>Foundation Medicine (<a href=\"https://seekingalpha.com/symbol/FMI\" title=\"Foundation Medicine, Inc.\">FMI</a> <font color=\"green\">+79%</font>) \u2014 which markets molecular information-enabled products to physicians and biopharma firms \u2014 <a href=\"http://www.streetinsider.com/Hot+IPOs/Foundation+Medicine+%28FMI%29+IPO+Jumps+Over+70%25/8720003.html\" target=\"_blank\">opens at</a> $31.50, well above its expected range of $14-16. Through June 30, the company had logged sales of $11.1M and incurred an operating loss of $17.1M.</li>     <li>Evoke Pharma (<a href=\"https://seekingalpha.com/symbol/EVOK\" title=\"Evoke Pharma, Inc.\">EVOK</a> <font color=\"red\">-5.8%</font>) \u2014 which develops treatments for GI diseases \u2014 <a href=\"http://www.streetinsider.com/IPOs/Evoke+Pharma+%28EVOK%29+IPO+Opens+Lower/8720159.html\" target=\"_blank\">opens at</a> $11.15, below its expected range of $12-14.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298742\" data-linked=\"Foundation Medicine soars in debut, Evoke underwhelms\" data-tweet=\"$FMI $FMI $EVOK - Foundation Medicine soars in debut, Evoke underwhelms https://seekingalpha.com/news/1298742-foundation-medicine-soars-in-debut-evoke-underwhelms?source=tweet\" data-url=\"https://seekingalpha.com/news/1298742-foundation-medicine-soars-in-debut-evoke-underwhelms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298692\" data-ts=\"1380124401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRS\" target=\"_blank\">HRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298692-raymond-james-upgrades-harris-corporation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raymond James upgrades Harris Corporation</a></h4><ul>\n<li>Harris Corporation (<a href=\"https://seekingalpha.com/symbol/HRS\" title=\"Harris Corporation\">HRS</a> <font color=\"green\">+2.6%</font>) rises after Raymond James gets bullish, <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/09/3941610/update-raymond-james-upgrades-harris-corporation-followi\" target=\"_blank\">upgrading the stock</a> to Outperform from Market Perform.</li>\n<li>Analyst Chris Quilty thinks the recent tactical radio contract win \"proves that HRS can successfully compete against larger, entrenched  competitors [and] could prove additive to FY14  earnings as well as the company's valuation multiple.\"</li>\n<li>Price target is $65.</li>\n<li>Previous: HRS lands <a href=\"https://seekingalpha.com/currents/post/1287232\" target=\"_blank\">$38M tactical radio order</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298692\" data-linked=\"Raymond James upgrades Harris Corporation\" data-tweet=\"$HRS $LHX - Raymond James upgrades Harris Corporation https://seekingalpha.com/news/1298692-raymond-james-upgrades-harris-corporation?source=tweet\" data-url=\"https://seekingalpha.com/news/1298692-raymond-james-upgrades-harris-corporation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298652\" data-ts=\"1380124043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AU\" target=\"_blank\">AU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298652-citi-stays-bearish-on-south-african-gold-miners\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi stays bearish on South African gold miners</a></h4><ul>     <li>Though gold futures are up ~1.5% today, Citi <a href=\"http://blogs.barrons.com/emergingmarketsdaily/2013/09/25/citi-wary-of-npv-valuation-bearish-on-south-african-miners-even-as-it-upgrades-gold-forecast/\" target=\"_blank\">remains negative on South African gold miners</a> because of weak balance sheets and negative cash flows.</li>     <li>Sell-rated AngloGold (<a href=\"https://seekingalpha.com/symbol/AU\" title=\"AngloGold Ashanti Limited\">AU</a> <font color=\"green\">+5.7%</font>) is \"badly positioned\" given a weak balance sheet, high capex commitments and the failure to dispose of high-cost, non-core assets, Citi says.</li>     <li>On Harmony Gold (<a href=\"https://seekingalpha.com/symbol/HMY\" title=\"Harmony Gold Mining Company Limited\">HMY</a> <font color=\"green\">+3.2%</font>), another Sell, the firm finds the touted Wafi/Golpu project unfeasible; the firm had estimated the project to have a negative NPV of $595M in a year-old analysis when its average gold price assumptions were ~30% above current spot prices.</li>     <li>The analysts have the most positive outlook on Gold Fields (<a href=\"https://seekingalpha.com/symbol/GFI\" title=\"Gold Fields Limited\">GFI</a> <font color=\"green\">+1.5%</font>), which is rated only at Neutral.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298652\" data-linked=\"Citi stays bearish on South African gold miners\" data-tweet=\"$AU $AU $HMY - Citi stays bearish on South African gold miners https://seekingalpha.com/news/1298652-citi-stays-bearish-on-south-african-gold-miners?source=tweet\" data-url=\"https://seekingalpha.com/news/1298652-citi-stays-bearish-on-south-african-gold-miners\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298632\" data-ts=\"1380123842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVAX\" target=\"_blank\">DVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298632-dynavax-rises-in-morning-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dynavax rises in morning trading</a></h4><ul>\n<li>Dynavax Technologies (<a href=\"https://seekingalpha.com/symbol/DVAX\" title=\"Dynavax Technologies Corporation\">DVAX</a> <font color=\"green\">+8.4%</font>) posts solid gains in morning trading.</li>\n<li>The company said Tuesday evening that  immunogenicity and safety results from two Phase 3 Heplisav trials were published in <em>Vaccine</em> along with some commentary by two doctors.</li>\n<li>Long story short, here's what was said: These two trials are further evidence that the adjuvant in Heplisav is \"important\" in hepatitis B immunization. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298632\" data-linked=\"Dynavax rises in morning trading\" data-tweet=\"$DVAX - Dynavax rises in morning trading https://seekingalpha.com/news/1298632-dynavax-rises-in-morning-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/1298632-dynavax-rises-in-morning-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298622\" data-ts=\"1380123644\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298622-t-mobile-cfo-merger-with-sprint-makes-sense\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile CFO: Merger with Sprint makes sense</a></h4><ul>\n<li>During a Goldman conference talk, T-Mobile USA (<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a> <font color=\"green\">+2.3%</font>) CFO Braxton Carter called a merger between his company and Sprint (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"red\">-2.3%</font>) the \"<a href=\"http://www.reuters.com/article/2013/09/25/us-tmobileus-consolidation-idUSBRE98O0PV20130925?feedType=RSS&amp;feedName=technologyNews\" target=\"_blank\">logical ultimate combination</a>.\" But he also admitted the current M&amp;A regulatory environment is \"tough.\"</li>\n<li>T-Mobile and Sprint have been bleeding share in recent years to bigger rivals Verizon and AT&amp;T. However, T-Mobile has begun to <a href=\"https://seekingalpha.com/currents/post/1277562\" target=\"_blank\">reverse its fortunes</a> with the help of an iPhone deal, contract-free plans, and its Jump smartphone upgrade program. Sprint is betting <a href=\"https://seekingalpha.com/currents/post/1281452\" target=\"_blank\">aggressive pricing</a> and a rapid 4G buildout will help it do the same.</li>\n<li>Regulators may not be the only reason a T-Mobile/Sprint deal would be challenging in the near-term. T-Mobile is in the midst of digesting MetroPCS, and Sprint is fresh off acquiring Clearwire and merging with SoftBank (<a href=\"https://seekingalpha.com/symbol/SFTBF\" title=\"SoftBank Group\">OTCPK:SFTBF</a>).</li>\n<li>Separately, <a href=\"http://www.fiercewireless.com/story/softbank-extends-sprint-ceo-hesses-contract-through-2018/2013-09-25?utm_source=Twitter&amp;utm_medium=Editor&amp;utm_campaign=SocialMedia\" target=\"_blank\">SoftBank has extended</a> Sprint CEO Dan Hesse's contract through July 2018.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298622\" data-linked=\"T-Mobile CFO: Merger with Sprint makes sense\" data-tweet=\"$TMUS $TMUS $S - T-Mobile CFO: Merger with Sprint makes sense https://seekingalpha.com/news/1298622-t-mobile-cfo-merger-with-sprint-makes-sense?source=tweet\" data-url=\"https://seekingalpha.com/news/1298622-t-mobile-cfo-merger-with-sprint-makes-sense\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298562\" data-ts=\"1380121895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFI\" target=\"_blank\">INFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298562-infinity-lower-but-stable-after-retaspimycin-hcl-miss-stifel-sees-opportunity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinity lower but stable after retaspimycin HCl miss, Stifel sees opportunity</a></h4><ul>\n<li>Infinity Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/INFI\" title=\"Infinity Pharmaceuticals, Inc.\">INFI</a> <font color=\"red\">-3.3%</font>) is off its lows hit earlier in the session after the company <a href=\"https://seekingalpha.com/currents/post/1298042\" target=\"_blank\">reported disappointing</a> (but perhaps not too surprising) results for its Hsp90 inhibitor in non-small cell lung cancer.</li>\n<li>Predictably, the sell-side is out in defense, with (according to <a href=\"https://twitter.com/ianestepan/status/382875949194563584\" target=\"_blank\">chatter</a>) Stifel reminding investors that retaspimycin hydrochloride was never in anyone's models in the first place.</li>\n<li>What you're likely to hear: \"Buy on weakness \u2014 it's all about the PI3K inhibitor.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298562\" data-linked=\"Infinity lower but stable after retaspimycin HCl miss, Stifel sees opportunity\" data-tweet=\"$INFI - Infinity lower but stable after retaspimycin HCl miss, Stifel sees opportunity https://seekingalpha.com/news/1298562-infinity-lower-but-stable-after-retaspimycin-hcl-miss-stifel-sees-opportunity?source=tweet\" data-url=\"https://seekingalpha.com/news/1298562-infinity-lower-but-stable-after-retaspimycin-hcl-miss-stifel-sees-opportunity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298502\" data-ts=\"1380120816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLUU\" target=\"_blank\">GLUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298502-glu-mobile-jumps-following-strong-deer-hunter-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glu Mobile jumps following strong Deer Hunter data</a></h4><ul>\n<li>Glu (<a href=\"https://seekingalpha.com/symbol/GLUU\" title=\"Glu Mobile Inc.\">GLUU</a> <font color=\"green\">+10.1%</font>) announces <em>Deer Hunter 2014</em>, which the company <a href=\"https://seekingalpha.com/currents/post/1289562\" target=\"_blank\">launched on iOS</a> last week, has been ranked the top free game in the App Store in 78 countries, and has been ranked the top free overall app in 19. (PR)</li>\n<li>Glu adds <em>Deer Hunter 2014</em> saw 5M+ downloads in its first 7 days of availability, and recorded 18M+ gameplay sessions in a single day. Both are new records for the game developer.</li>\n<li>\n<em>Deer Hunter 2014</em> is <a href=\"http://www.appannie.com/top/\" target=\"_blank\">currently at #2</a> on App Annie's U.S. iPhone free download chart ranks, trailing only Electronic Arts' (<a href=\"https://seekingalpha.com/symbol/EA\" title=\"Electronic Arts Inc.\">EA</a> <font color=\"green\">+0.1%</font>) just-launched <a href=\"https://seekingalpha.com/currents/post/1297462\" target=\"_blank\"><em>FIFA 14</em></a>. On the <a href=\"http://www.appannie.com/top/ipad/united-states/\" target=\"_blank\">iPad</a>, <em>Deer Hu</em>nte<em>r 2014 </em> is #5, and <em>FIFA 14</em> is #6.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298502\" data-linked=\"Glu Mobile jumps following strong Deer Hunter data\" data-tweet=\"$GLUU $GLUU $EA - Glu Mobile jumps following strong Deer Hunter data https://seekingalpha.com/news/1298502-glu-mobile-jumps-following-strong-deer-hunter-data?source=tweet\" data-url=\"https://seekingalpha.com/news/1298502-glu-mobile-jumps-following-strong-deer-hunter-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298482\" data-ts=\"1380120258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLE\" target=\"_blank\">EGLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298482-dry-bulk-shippers-on-the-move-as-rates-spike-overnight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dry bulk shippers on the move as rates spike overnight</a></h4><ul>     <li>Dry bulk shipping rates are <a href=\"http://www.dryships.com/pages/report.asp\" target=\"_blank\">rising again</a>: Overnight, capesize rates rose 5.2% (or $2,206/day) to $42,211/day, panamax rates rose 8.9% (or $1,144) to $13,989/day, and supramax rates rose 2.6% to $10,579/day.</li>     <li>Since Aug. 12, capesize rates are up 300%, largely driven by higher iron ore shipments to China out of Brazil and Australia, while panamax rates are up 87%, largely driven by coal activity and anticipation of a good amount of shipments from a bountiful U.S. harvest (Briefing.com).</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/EGLE\" title=\"Eagle Bulk Shipping Inc.\">EGLE</a> <font color=\"green\">+6.2%</font>, FREE <font color=\"green\">+5.6%</font>, <a href=\"https://seekingalpha.com/symbol/SINO\" title=\"Sino-Global Shipping America, Ltd.\">SINO</a> <font color=\"green\">+5.1%</font>, VLCCF <font color=\"green\">+4.5%</font>, <a href=\"https://seekingalpha.com/symbol/DRYS\" title=\"DryShips Inc.\">DRYS</a> <font color=\"green\">+4.2%</font>, <a href=\"https://seekingalpha.com/symbol/BALT\" title=\"Baltic Trading Limited\">BALT</a> <font color=\"green\">+4%</font>, PRGN <font color=\"green\">+3.4%</font>, <a href=\"https://seekingalpha.com/symbol/DSX\" title=\"Diana Shipping, Inc.\">DSX</a> <font color=\"green\">+1.6%</font>, <a href=\"https://seekingalpha.com/symbol/ULTR\" title=\"Ultrapetrol (Bahamas) Limited\">ULTR</a> <font color=\"green\">+1.2%</font>, <a href=\"https://seekingalpha.com/symbol/NM\" title=\"Navios Maritime Holdings Inc.\">NM</a> <font color=\"green\">+1%</font>, <a href=\"https://seekingalpha.com/symbol/SB\" title=\"Safe Bulkers Inc.\">SB</a> <font color=\"green\">+0.9%</font>, <a href=\"https://seekingalpha.com/symbol/SFL\" title=\"Ship Finance International Limited\">SFL</a> <font color=\"green\">+0.7%</font>, <a href=\"https://seekingalpha.com/symbol/NMM\" title=\"Navios Maritime Partners L.P.\">NMM</a>  <font color=\"green\">+0.5%</font>, <a href=\"https://seekingalpha.com/symbol/KEX\" title=\"Kirby Corporation\">KEX</a> <font color=\"green\">+0.3%</font>, <a href=\"https://seekingalpha.com/symbol/DCIX\" title=\"Diana Containerships Inc.\">DCIX</a> <font color=\"green\">+0.3%</font>, <a href=\"https://seekingalpha.com/symbol/SBLK\" title=\"Star Bulk Carriers Corp.\">SBLK</a> <font color=\"green\">+0.3%</font>, <a href=\"https://seekingalpha.com/symbol/GNK\" title=\"Genco Shipping &amp; Trading Ltd.\">GNK</a> <font color=\"green\">+0.2%</font>.</li>     <li>However, Seanergy (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SHIP\" title=\"Seanergy Maritime Holdings Corp\">SHIP</a>) <font color=\"red\">-15.3%</font> after <a href=\"https://seekingalpha.com/currents/post/1297952\" target=\"_blank\">reporting earnings</a> this morning and reigniting concerns about its ability to stay in business.</li>     <li>ETF: <a href=\"https://seekingalpha.com/symbol/SEA\" title=\"Invesco Shipping ETF\">SEA</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298482\" data-linked=\"Dry bulk shippers on the move as rates spike overnight\" data-tweet=\"$EGLE $EGLE $FREEF - Dry bulk shippers on the move as rates spike overnight https://seekingalpha.com/news/1298482-dry-bulk-shippers-on-the-move-as-rates-spike-overnight?source=tweet\" data-url=\"https://seekingalpha.com/news/1298482-dry-bulk-shippers-on-the-move-as-rates-spike-overnight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298472\" data-ts=\"1380119762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYK\" target=\"_blank\">SYK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298472-wells-fargo-still-bullish-on-stryker-after-pricey-mako-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo still bullish on Stryker after pricey Mako deal</a></h4><ul><li>Stryker (<a href='https://seekingalpha.com/symbol/SYK' title='Stryker Corporation'>SYK</a> <font color='red'>-2.3%</font>) \"is paying 12.4x EV/sales [for <a href='https://seekingalpha.com/symbol/MAKO' title='MAKO Surgical Corp.'>MAKO</a>] on our 2013 sales estimate which is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/09/3941295/wells-fargo-reiterates-outperform-on-stryker-following-a\" target=\"_blank\">relatively high</a>,\" Wells Fargo's Larry Biegelsen notes, adding that \"the 2 most recent ortho deals, MDT's acquisition of Kanghui and SYK's  acquisition of Trauson went for 11.6x and 8.7x, on an EV/sales basis  respectively.\"</li><li>Nevertheless, Biegelsen thinks SYK is getting a \"differentiated asset\" &mdash; Wells has been bullish on MAKO since May. SYK is reiterated at Outperform.</li><li>TheStreet's Antoine Gara notes that as of September 13, 22% of MAKO's float <a href=\"http://www.thestreet.com/story/12048229/1/strykers-30-a-share-mako-surgical-deal-smokes-out-shorts.html\" target=\"_blank\">was sold short</a>.</li><li>More on the deal <a href=\"https://seekingalpha.com/currents/search?query=mako+stryker\" target=\"_blank\">here</a></li></ul><div class=\"tiny-share-widget\" data-id=\"1298472\" data-linked=\"Wells Fargo still bullish on Stryker after pricey Mako deal\" data-tweet=\"$SYK $SYK $MAKO - Wells Fargo still bullish on Stryker after pricey Mako deal https://seekingalpha.com/news/1298472-wells-fargo-still-bullish-on-stryker-after-pricey-mako-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1298472-wells-fargo-still-bullish-on-stryker-after-pricey-mako-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298452\" data-ts=\"1380119493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNXL\" target=\"_blank\">UNXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298452-unipixel-provides-business-update-shares-soar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniPixel provides business update, shares soar</a></h4><ul>\n<li>UniPixel (<a href=\"https://seekingalpha.com/symbol/UNXL\" title=\"Uni-Pixel, Inc.\">UNXL</a> <font color=\"green\">+18.6%</font>) states there are now three plating lines being used to produce's the company's metal mesh touch sensors, up from a prior one, and that manufacturing partner Kodak (<a href=\"https://seekingalpha.com/currents/post/945301\" target=\"_blank\">previous</a>) is expected to have four plating lines and two printing lines operational by Q4. More capacity is set to be added in 2014. (PR)</li>\n<li>Moreover, UniPixel and Kodak have begun talking with \"several manufacturing companies in Asia\" that have shown interest in manufacturing their sensors.</li>\n<li>Also: UniPixel is rebranding its touch sensors, until now known as UniBoss, as InTouch.</li>\n<li>52.5% of the float was shorted as of Aug. 30.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298452\" data-linked=\"UniPixel provides business update, shares soar\" data-tweet=\"$UNXL - UniPixel provides business update, shares soar https://seekingalpha.com/news/1298452-unipixel-provides-business-update-shares-soar?source=tweet\" data-url=\"https://seekingalpha.com/news/1298452-unipixel-provides-business-update-shares-soar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298422\" data-ts=\"1380119045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298422-j-c-penney-hits-12-year-lows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney hits 12-year lows</a></h4><ul> <li>J.C Penney (<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a> <font color=\"red\">-13.6%</font>) falls on heavy volume as the bad news for the retailer keeps piling up.</li> <li>Cleveland Research says its channel checks show JCP's Q3 sales are weak and isn't predicting positive comparable store sales growth for Q4.</li> <li>Goldman Sachs has its hands deep into the J.C. Penney mess with loans and investment banking advice, but that isn't stopping the firm from issuing a <a href=\"http://www.zerohedge.com/news/2013-09-24/goldman-goes-medieval-jcpenney-shorts-bonds-slams-liquidity-expects-default-risk-sur\" target=\"_blank\">dire report</a> this morning that's tipping sentiment.</li> <li>Bill Ackman left the JCP party early - but George Soros, Glenview Capital, and Mark Cuban are still around to turn off the lights.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298422\" data-linked=\"J.C. Penney hits 12-year lows\" data-tweet=\"$JCP - J.C. Penney hits 12-year lows https://seekingalpha.com/news/1298422-j-c-penney-hits-12-year-lows?source=tweet\" data-url=\"https://seekingalpha.com/news/1298422-j-c-penney-hits-12-year-lows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298392\" data-ts=\"1380118198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KERX\" target=\"_blank\">KERX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298392-keryx-biopharmaceuticals-jumps-on-bullish-coverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keryx Biopharmaceuticals jumps on bullish coverage</a></h4><ul>     <li>Keryx Biopharmaceuticals (<a href=\"https://seekingalpha.com/symbol/KERX\" title=\"Keryx Biopharmaceuticals, Inc.\">KERX</a> <font color=\"green\">+6.3%</font>) surges after HC Wainwright starts the shares at Buy. <br>     </li>     <li>Price target is $15 \u2014 that's a <font color=\"green\">53%</font> premium to Tuesday's close.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298392\" data-linked=\"Keryx Biopharmaceuticals jumps on bullish coverage\" data-tweet=\"$KERX - Keryx Biopharmaceuticals jumps on bullish coverage https://seekingalpha.com/news/1298392-keryx-biopharmaceuticals-jumps-on-bullish-coverage?source=tweet\" data-url=\"https://seekingalpha.com/news/1298392-keryx-biopharmaceuticals-jumps-on-bullish-coverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298332\" data-ts=\"1380117237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPSP\" target=\"_blank\">NPSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298332-janney-ups-target-on-nps-pharma-sees-off-label-gattex-reimbursement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Janney ups target on NPS Pharma, sees off-label Gattex reimbursement</a></h4><ul>\n<li>Janney <a href=\"https://twitter.com/thenotablecalls/status/382860966842466305\" target=\"_blank\">sees evidence</a> of off-label reimbursement for the NPS Pharmaceuticals' (<a href=\"https://seekingalpha.com/symbol/NPSP\" title=\"NPS Pharmaceuticals, Inc.\">NPSP</a> <font color=\"green\">+2%</font>) SBS treatment <a href=\"https://seekingalpha.com/currents/search?query=gattex\" target=\"_blank\">Gattex</a>. That's good news considering there are questions regarding insurer coverage push back.</li>\n<li>Analyst Jim Molloy speculates Cigna and Blue Cross are <a href=\"https://twitter.com/thenotablecalls/status/382861099671900160\" target=\"_blank\">already reimbursing</a> off-label use. Janney's <a href=\"http://www.streetinsider.com/Analyst+PT+Change/NPS+Pharma+%28NPSP%29+Target+Raised+to+%2445+at+Janney/8719808.html\" target=\"_blank\">new price target</a> for NPSP is $45.</li>\n<li>Many commentators, including SA contributor <a href=\"https://seekingalpha.com/article/1629442-nps-pharmaceuticals-has-a-billion-plus-blockbuster-on-its-hands\" target=\"_blank\">Cory Renauer</a> and Oppenheimer's Boris Peaker, are bullish on the drug.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298332\" data-linked=\"Janney ups target on NPS Pharma, sees off-label Gattex reimbursement\" data-tweet=\"$NPSP - Janney ups target on NPS Pharma, sees off-label Gattex reimbursement https://seekingalpha.com/news/1298332-janney-ups-target-on-nps-pharma-sees-off-label-gattex-reimbursement?source=tweet\" data-url=\"https://seekingalpha.com/news/1298332-janney-ups-target-on-nps-pharma-sees-off-label-gattex-reimbursement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298312\" data-ts=\"1380116626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DB\" target=\"_blank\">DB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298312-deutsche-adds-to-bank-warnings-over-trading-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche adds to bank warnings over trading revenue</a></h4><ul>\n<li>Speaking at BAML's Banking and Insurance Conference in London, Deutsche Bank (<a href=\"https://seekingalpha.com/symbol/DB\" title=\"Deutsche Bank AG\">DB</a> <font color=\"red\">-1.6%</font>) co-CEO says the bank expects a \"significant\" drop in Q3 trading revenue.</li>\n<li>The announcement isn't unexpected, and follows <a href=\"https://seekingalpha.com/currents/post/1293052\" target=\"_blank\">a similar warning</a> from Citigroup over the weekend, numerous other rumblings from investor conferences this month, and Jefferies' <a href=\"https://seekingalpha.com/currents/post/1284602\" target=\"_blank\">already reported</a> ugly (from a trading standpoint) Q3.</li>\n<li>Previous: FICC trading revenue <a href=\"https://seekingalpha.com/currents/post/1296872\" target=\"_blank\">has been slipping</a> for years and should be in analyst models by this point.</li>\n<li>Banks (<a href=\"https://seekingalpha.com/symbol/KRE\" title=\"SPDR S&amp;P Regional Banking ETF\">KRE</a> <font color=\"red\">-0.6%</font>), (<a href=\"https://seekingalpha.com/symbol/KBE\" title=\"SPDR S&amp;P Bank ETF\">KBE</a> <font color=\"red\">-0.4%</font>) again are leading the market decline.</li>\n<li>Financials ETFs: <a href=\"https://seekingalpha.com/symbol/XLF\" title=\"Financial Select Sector SPDR ETF\">XLF</a>, <a href=\"https://seekingalpha.com/symbol/IYF\" title=\"iShares U.S. Financials ETF\">IYF</a>, <a href=\"https://seekingalpha.com/symbol/PFI\" title=\"Invesco DWA Financial Momentum Portfolio ETF\">PFI</a>, <a href=\"https://seekingalpha.com/symbol/VFH\" title=\"Vanguard Financials ETF\">VFH</a>, <a href=\"https://seekingalpha.com/symbol/RYF\" title=\"Invesco S&amp;P Equal Weight Financial ETF\">RYF</a>, <a href=\"https://seekingalpha.com/symbol/RWW\" title=\"Oppenheimer Financials Sector Revenue ETF\">RWW</a>, <a href=\"https://seekingalpha.com/symbol/FAS\" title=\"Direxion Daily Financial Bull 3x Shares ETF\">FAS</a>, <a href=\"https://seekingalpha.com/symbol/UYG\" title=\"ProShares Ultra Financials ETF\">UYG</a>, <a href=\"https://seekingalpha.com/symbol/FAZ\" title=\"Direxion Daily Financial Bear 3x Shares ETF\">FAZ</a>, <a href=\"https://seekingalpha.com/symbol/SKF\" title=\"ProShares UltraShort Financials ETF\">SKF</a>, <a href=\"https://seekingalpha.com/symbol/SEF\" title=\"ProShares Short Financials ETF\">SEF</a>, <a href=\"https://seekingalpha.com/symbol/IAI\" title=\"iShares U.S. Broker-Dealers &amp; Securities Exchanges ETF\">IAI</a>, <a href=\"https://seekingalpha.com/symbol/FXO\" title=\"First Trust Financials AlphaDEX ETF\">FXO</a>, <a href=\"https://seekingalpha.com/symbol/PSCF\" title=\"Invesco S&amp;P SmallCap Financials Portfolio ETF\">PSCF</a>, <a href=\"https://seekingalpha.com/symbol/KBWD\" title=\"Invesco KBW High Dividend Yield Financial Portfolio ETF\">KBWD</a>, <a href=\"https://seekingalpha.com/symbol/KBWB\" title=\"Invesco KBW Bank Portfolio ETF\">KBWB</a>, <a href=\"https://seekingalpha.com/symbol/IYG\" title=\"iShares U.S. Financial Services ETF\">IYG</a>, <a href=\"https://seekingalpha.com/symbol/FINU\" title=\"ProShares UltraPro Financials ETF\">FINU</a>, <a href=\"https://seekingalpha.com/symbol/FINZ\" title=\"ProShares UltraPro Short Financials ETF\">FINZ</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298312\" data-linked=\"Deutsche adds to bank warnings over trading revenue\" data-tweet=\"$DB $DB $KRE - Deutsche adds to bank warnings over trading revenue https://seekingalpha.com/news/1298312-deutsche-adds-to-bank-warnings-over-trading-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1298312-deutsche-adds-to-bank-warnings-over-trading-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298302\" data-ts=\"1380116519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCL\" target=\"_blank\">CCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298302-carnival-hit-with-downgrades-post-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carnival hit with downgrades post-earnings</a></h4><ul> <li>Carnival (<a href=\"https://seekingalpha.com/symbol/CCL\" title=\"Carnival Corporation\">CCL</a> <font color=\"red\">-4.3%</font>) trades lower with a several analyst downgrades driving sentiment lower.</li> <li>Morgan Stanley <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/09/3940980/update-bank-of-america-downgrades-carnival-on-continued-#\" target=\"_blank\">lowers</a> its rating to Underweight from Equal-Weight while BofA slots shares at Neutral.</li> <li>Pricing in the sector remains a concern.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298302\" data-linked=\"Carnival hit with downgrades post-earnings\" data-tweet=\"$CCL - Carnival hit with downgrades post-earnings https://seekingalpha.com/news/1298302-carnival-hit-with-downgrades-post-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1298302-carnival-hit-with-downgrades-post-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298292\" data-ts=\"1380116276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPTP\" target=\"_blank\">RPTP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298292-raptor-pharmaceuticals-slides-as-oppenheimer-outlines-risks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raptor Pharmaceuticals slides as Oppenheimer outlines risks</a></h4><ul>\n<li>Raptor Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RPTP\" title=\"Raptor Pharmaceutical Corp.\">RPTP</a>) falls in early trading on the heels of an Oppenheimer downgrade.</li>\n<li>\"We believe that the market is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/09/3940860/update-oppenheimer-downgrades-raptor-pharmaceutical-as-p\" target=\"_blank\">already pricing in</a> <a href=\"https://seekingalpha.com/currents/search?query=Procysbi\" target=\"_blank\">Procysbi</a> adoption by 80%+ patients in the US and EU at current valuation,\" analyst Boris Peaker says, removing his $11 price target.</li>\n<li>Oppenheimer also says success in Huntington's (<a href=\"https://seekingalpha.com/currents/search?query=rp103\" target=\"_blank\">RP103</a>) is critical for RPTP \u2014 \"we view [this] as very risky,\" Peaker notes.</li>\n<li>Another concern:  Procysbi pricing in Europe as \"reimbursement may be more challenging\" than in the U.S. See: Procysbi gets EU <a href=\"https://seekingalpha.com/currents/post/1276192\" target=\"_blank\">marketing authorization</a>.<br><div> </div>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298292\" data-linked=\"Raptor Pharmaceuticals slides as Oppenheimer outlines risks\" data-tweet=\"$RPTP - Raptor Pharmaceuticals slides as Oppenheimer outlines risks https://seekingalpha.com/news/1298292-raptor-pharmaceuticals-slides-as-oppenheimer-outlines-risks?source=tweet\" data-url=\"https://seekingalpha.com/news/1298292-raptor-pharmaceuticals-slides-as-oppenheimer-outlines-risks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298272\" data-ts=\"1380116250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298272-blackberry-slides-as-doubts-grow-about-fairfaxs-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry slides as doubts grow about Fairfax&#39;s offer</a></h4><ul>\n<li>With Prem Watsa's Fairfax Financial <a href=\"https://seekingalpha.com/currents/post/1295392\" target=\"_blank\">not putting additional cash</a> into its BlackBerry (BBRY <font color=\"red\">-2.2%</font>) acquisition offer and having failed to provide details about its buyout consortium, skepticism is growing the deal will get the financing it needs.</li>\n<li>Wedge Partners' <a href=\"http://allthingsd.com/20130924/what-does-prem-watsa-see-in-blackberry/\" target=\"_blank\">Brian Blair</a>: \"Watsa is trying to salvage his 10 percent investment in the company and create a backstop while other potential investors hopefully bid it up.\"</li>\n<li>Fund manager <a href=\"http://www.bloomberg.com/news/2013-09-25/blackberry-patents-key-to-raising-buyout-debt-canada-credit.html\" target=\"_blank\">Marc Gross</a> suggests financing could arrive if it's secured by BlackBerry's patents. Raymond James estimates the company's patents, software licenses, and network could be worth $2.8B.</li>\n<li>Watsa, for his part, is making the case his deal <a href=\"http://www.reuters.com/article/2013/09/24/us-blackberry-offer-review-idUSBRE98N12320130924?feedType=RSS&amp;feedName=technologyNews\" target=\"_blank\">would avoid</a> the regulatory review that would come if BlackBerry was to be acquired by a foreign firm.</li>\n<li>Shares are now 7% below Fairfax's offer price, and not far removed from where they traded before the deal announcement.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298272\" data-linked=\"BlackBerry slides as doubts grow about Fairfax&#39;s offer\" data-tweet=\"$BB - BlackBerry slides as doubts grow about Fairfax&#39;s offer https://seekingalpha.com/news/1298272-blackberry-slides-as-doubts-grow-about-fairfaxs-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/1298272-blackberry-slides-as-doubts-grow-about-fairfaxs-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298242\" data-ts=\"1380115400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298242-kb-home-looks-to-add-to-big-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Home looks to add to big gains</a></h4><ul>     <li>KB Home (NYSE:<a href=\"https://seekingalpha.com/symbol/KBH\" title=\"KB Home\">KBH</a>) looks to add to yesterday's big <a href=\"https://seekingalpha.com/currents/post/1296142\" target=\"_blank\">post-earnings</a> gain, <font color=\"green\">up 1.2%</font> premarket after ISI Group<a href=\"http://www.streetinsider.com/Upgrades/ISI+Group+Upgrades+KB+Home+%28KBH%29+to+Neutral/8719034.html\" target=\"_blank\"> pulls its Sell</a> rating on the stock.</li>     <li>Addressing the Y/Y decline in unit sales, management (<a href=\"https://seekingalpha.com/article/1711302-kb-home-management-discusses-q3-2013-results-earnings-call-transcript?part=single\" target=\"_blank\">earnings call transcript</a>) talks of a deliberate attempt to move away from lower-margin inland California home sales, and instead focus on the coastal regions. 66% of California revenue came from coastal divisions, \"a significant flip\" from the historic mix. With just 14 additional units delivered in CA from the previous year, revenue was up by about $50M.</li>     <li>Another factor behind the decline was the delay in the openings of 7 communities, allowing just one month of sales prior to the end of the quarter. Business is brisk though, says management, with pricing and margin well above projections.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298242\" data-linked=\"KB Home looks to add to big gains\" data-tweet=\"$KBH - KB Home looks to add to big gains https://seekingalpha.com/news/1298242-kb-home-looks-to-add-to-big-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/1298242-kb-home-looks-to-add-to-big-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298222\" data-ts=\"1380115111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298222-indonesia-slides-again-thailand-rebounds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Indonesia slides again, Thailand rebounds</a></h4><ul>     <li>It's another down day for Indonesian equities (<a href='https://seekingalpha.com/symbol/idx' title='Market Vectors Indonesia Index ETF'>IDX</a>, <a href='https://seekingalpha.com/symbol/eido' title='iShares MSCI Indonesia ETF'>EIDO</a>, <a href='https://seekingalpha.com/symbol/idxj' title='Market Vectors Indonesia Small Cap ETF'>IDXJ</a>) as foreign investors <a href=\"http://uk.reuters.com/article/2013/09/25/markets-southeastasia-stocks-idUKL4N0HL0T120130925\" target=\"_blank\">dump</a> nearly $50B worth of shares, according to Reuters. The JCI is off <font color='red'>1.2%</font> in Jakarta.</li>     <li>Elsewhere, Thai shares (<a href='https://seekingalpha.com/symbol/thd' title='iShares MSCI Thailand Capped ETF'>THD</a>, <a href='https://seekingalpha.com/symbol/tf' title='Thai Capital Fund'>TF</a>, <a href='https://seekingalpha.com/symbol/ttf' title='Thai Fund'>TTF</a>)&nbsp; jump <font color='green'>1.4%</font>, recouping some <a href=\"https://seekingalpha.com/currents/post/1294052\" target=\"_blank\">Monday</a> and <a href=\"https://seekingalpha.com/currents/post/1296212\" target=\"_blank\">Tuesday's</a> losses.</li>     <li>Malaysian (<a href='https://seekingalpha.com/symbol/ewm' title='iShares MSCI Malaysia ETF'>EWM</a>)&nbsp;and Philippine (<a href='https://seekingalpha.com/symbol/ephe' title='iShares MSCI Philippines ETF'>EPHE</a>) markets are weaker by <font color='red'>0.5%</font> and <font color='red'>0.6%</font> respectively, while Vietnamese shares (<a href='https://seekingalpha.com/symbol/vnm' title='Market Vectors Vietnam ETF'>VNM</a>) extend their rally.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298222\" data-linked=\"Indonesia slides again, Thailand rebounds\" data-tweet=\"$IDX $EIDO $IDXJ - Indonesia slides again, Thailand rebounds https://seekingalpha.com/news/1298222-indonesia-slides-again-thailand-rebounds?source=tweet\" data-url=\"https://seekingalpha.com/news/1298222-indonesia-slides-again-thailand-rebounds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298212\" data-ts=\"1380115074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298212-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul>     <li>Facebook (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FB\" title=\"Facebook\">FB</a>) has been started at Buy by Canaccord. Plenty of others on the sell-side have already <a href=\"http://www.streetinsider.com/rating_history.php?q=fb\" target=\"_blank\">turned bullish</a> since the July 24 Q2 report. Shares <font color=\"green\">+1.6%</font> premarket.</li>     <li>Silver Spring (NYSE:<a href=\"https://seekingalpha.com/symbol/SSNI\" title=\"Silver Spring Networks\">SSNI</a>) has been upgraded to Buy by Goldman. Shares <font color=\"green\">+7.1%</font>.</li>     <li>Ctrip (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTRP\" title=\"Ctrip.com International, Ltd.\">CTRP</a>) has been upgraded to Buy by Deutsche. Shares <font color=\"green\">+5.5%</font>.</li>     <li>Infosys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INFY\" title=\"Infosys Limited, Inc.\">INFY</a>) has been upgraded to Outperform by Baird. Shares <font color=\"green\">+1.1%</font>.</li>     <li>Skyworks (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SWKS\" title=\"Skyworks Solutions, Inc.\">SWKS</a>) and Semtech (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SMTC\" title=\"Semtech Corporation\">SMTC</a>) have been cut to Neutral by B. Riley. <a href=\"https://seekingalpha.com/symbol/SWKS\" title=\"Skyworks Solutions, Inc.\">SWKS</a> <font color=\"red\">-0.7%</font>.</li>     <li>Cypress (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CY\" title=\"Cypress Semiconductor Corporation\">CY</a>) has been cut to Neutral by Wedbush a day after issuing a <a href=\"https://seekingalpha.com/currents/post/1296082\" target=\"_blank\">Q3/Q4 warning</a> and getting downgraded by <a href=\"https://seekingalpha.com/currents/post/1296952\" target=\"_blank\">Needham</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298212\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$FB $FB $SSNI - A roundup of tech ratings changes https://seekingalpha.com/news/1298212-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1298212-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298182\" data-ts=\"1380114940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298182-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/MAKO\" title=\"MAKO Surgical Corp.\">MAKO</a> <font color=\"green\">+83%</font>. ONTY <font color=\"green\">+27%</font>. <a href=\"https://seekingalpha.com/symbol/ASNA\" title=\"Ascena Retail Group Inc\">ASNA</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/CTIC\" title=\"CTI BioPharma Corp.\">CTIC</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/STXS\" title=\"Stereotaxis, Inc.\">STXS</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/SBGL\" title=\"Sibanye-Stillwater\">SBGL</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/SSNI\" title=\"Silver Spring Networks\">SSNI</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/GLUU\" title=\"Glu Mobile Inc.\">GLUU</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/UNXL\" title=\"Uni-Pixel, Inc.\">UNXL</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/DVAX\" title=\"Dynavax Technologies Corporation\">DVAX</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/CTRP\" title=\"Ctrip.com International, Ltd.\">CTRP</a> <font color=\"green\">+6%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/CLVS\" title=\"Clovis Oncology\">CLVS</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/CLDT\" title=\"Chatham Lodging Trust\">CLDT</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/LLEN\" title=\"L&amp;L Energy, Inc.\">LLEN</a> <font color=\"red\">-5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1298182\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$MAKO $CASC $ASNA - Premarket Gainers / Losers https://seekingalpha.com/news/1298182-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1298182-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298082\" data-ts=\"1380113572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYK\" target=\"_blank\">SYK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298082-intuitive-surgical-accuray-spike-on-mako-takeout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuitive Surgical, Accuray spike on Mako takeout</a></h4><ul>     <li>Predictably, robotic surgery names are getting a lift from news Stryker (NYSE:<a href=\"https://seekingalpha.com/symbol/SYK\" title=\"Stryker Corporation\">SYK</a>) is <a href=\"https://seekingalpha.com/currents/post/1297982\" target=\"_blank\">acquiring</a> Mako (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MAKO\" title=\"MAKO Surgical Corp.\">MAKO</a>) for what seems like a staggering premium.</li>     <li>Premarket movers: MAKO <font color=\"green\">+83%</font> <a href=\"https://seekingalpha.com/symbol/ISRG\" title=\"Intuitive Surgical, Inc.\">ISRG</a> <font color=\"green\">+2.9%</font>, <a href=\"https://seekingalpha.com/symbol/ARAY\" title=\"Accuray Incorporated\">ARAY</a> <font color=\"green\">+3.7%</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298082\" data-linked=\"Intuitive Surgical, Accuray spike on Mako takeout\" data-tweet=\"$SYK $SYK $MAKO - Intuitive Surgical, Accuray spike on Mako takeout https://seekingalpha.com/news/1298082-intuitive-surgical-accuray-spike-on-mako-takeout?source=tweet\" data-url=\"https://seekingalpha.com/news/1298082-intuitive-surgical-accuray-spike-on-mako-takeout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1298042\" data-ts=\"1380112524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFI\" target=\"_blank\">INFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1298042-infinity-pharmaceuticals-slides-as-hsp90-inhibitor-misses-in-phase-2-nsclc-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinity Pharmaceuticals slides as Hsp90 inhibitor misses in Phase 2 NSCLC study</a></h4><ul>     <li>Infinity Pharmaceuticals' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INFI\" title=\"Infinity Pharmaceuticals, Inc.\">INFI</a>) Hsp90 inhibitor retaspimycin hydrochloride missed its efficacy endpoints in a Phase 2 non-small cell lung cancer study.</li>     <li>That's it for  retaspimycin HCl apparently: \"The company will not initiate any new trials.\"</li>     <li>INFI will focus on <a href=\"https://seekingalpha.com/currents/search?query=IPI-145\" target=\"_blank\">IPI-145</a> (the PI3K inhibitor) going forward. (PR)</li>     <li>INFI <font color=\"red\">-3%</font> premarket.</li>\n<li>Keep an eye on Synta Pharmaceuticals (SNTA) \u2014 <a href=\"https://seekingalpha.com/currents/search?query=ganetespib\" target=\"_blank\">ganetespib</a> is an Hsp90 inhibitor.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1298042\" data-linked=\"Infinity Pharmaceuticals slides as Hsp90 inhibitor misses in Phase 2 NSCLC study\" data-tweet=\"$INFI $INFI $MDGL - Infinity Pharmaceuticals slides as Hsp90 inhibitor misses in Phase 2 NSCLC study https://seekingalpha.com/news/1298042-infinity-pharmaceuticals-slides-as-hsp90-inhibitor-misses-in-phase-2-nsclc-study?source=tweet\" data-url=\"https://seekingalpha.com/news/1298042-infinity-pharmaceuticals-slides-as-hsp90-inhibitor-misses-in-phase-2-nsclc-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1297862\" data-ts=\"1380109495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1297862-dead-retailer-walking\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dead retailer walking?</a></h4><ul> <li>J.C. Penney (NYSE:<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a>) is in court today in New York to find out how it might fare over its contract with Martha Stewart Living Omnimedia, but bigger issues are dominating the discussion on the retailer.</li> <li>\n<a href=\"https://seekingalpha.com/currents/post/1292372\" target=\"_blank\">Negative cash flow</a> and massive debt have skeptics wondering if it can make intact to the cash-heavy holiday season.</li> <li>Retail analyst Brian Sozzi <a href=\"https://twitter.com/BrianSozzi/status/382828219873107969\" target=\"_blank\">thinks</a> continued share price weakness this week could indicate a \"release\" is coming from the company on September 30.</li> <li>Shares of JCP are <font color=\"red\">down 1.6%</font> premarket to $11.71 to mark their lowest level since January 2001.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1297862\" data-linked=\"Dead retailer walking?\" data-tweet=\"$JCP - Dead retailer walking? https://seekingalpha.com/news/1297862-dead-retailer-walking?source=tweet\" data-url=\"https://seekingalpha.com/news/1297862-dead-retailer-walking\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1297832\" data-ts=\"1380108943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASC\" target=\"_blank\">CASC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1297832-merck-to-take-oncothyreon-cancer-drug-into-new-phase-iii-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merck to take Oncothyreon cancer drug into new Phase III trial</a></h4><ul>   <li>Oncothyreon (ONTY) <font color=\"green\">surges 29%</font> after saying that Merck KGa (<a href=\"https://seekingalpha.com/symbol/MKGAF\" title=\"Merck KGaA\">OTCPK:MKGAF</a>) intends to carry out a Phase III trial of Oncothyreon's tecemotide immunotherapy in patients with advanced non-small cell lung cancer.</li>    <li>While tecemotide failed to meet the primary goal of a previous trial of improving survival in the overall patient population, the drug did achieve survival times 30.8 months vs 20.6 months for a placebo  in a sub-group. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1297832\" data-linked=\"Merck to take Oncothyreon cancer drug into new Phase III trial\" data-tweet=\"$CASC $CASC $MKGAF - Merck to take Oncothyreon cancer drug into new Phase III trial https://seekingalpha.com/news/1297832-merck-to-take-oncothyreon-cancer-drug-into-new-phase-iii-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/1297832-merck-to-take-oncothyreon-cancer-drug-into-new-phase-iii-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1297632\" data-ts=\"1380099263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1297632-world-shares-fall-on-u-s-fears\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">World shares fall on U.S. fears</a></h4><ul>   <li>\n<a href=\"http://www.reuters.com/article/2013/09/25/us-markets-global-idUSBRE96S00E20130925\" target=\"_blank\">Global equities</a> are lower as the deadline for a U.S. budget deal draws closer and investors wonder what the Fed will do next after it backed out of tapering last week.</li>    <li>\"We're not seeing a post-Fed party as perhaps the market was initially expecting and that's causing some safe-haven flows,\" says FXPro chief economist Simon Smith.</li>    <li>The USD-JPY is <font color=\"red\">-0.2%</font> to ¥98.52 and gold is <font color=\"green\">+0.4%</font> to $1.321.20. The U.S. dollar index is <font color=\"red\">-0.1%</font>.</li>    <li>In Japan, Tokyo Electron <font color=\"green\">surges 13.2%</font> on its merger with Applied Materials.</li>    <li>Japan <font color=\"red\">-0.8%</font>, Hong Kong <font color=\"green\">+0.1%</font>, China <font color=\"red\">-0.4%</font>, India <font color=\"red\">-0.9%</font>.</li>    <li>EU Stoxx 50 <font color=\"red\">-0.1%</font>, London <font color=\"red\">-0.1%</font>. Paris <font color=\"red\">-0.1%</font>. Frankfurt <font color=\"red\">-0.1%</font>, Milan <font color=\"red\">-0.15%</font>, <font color=\"red\">-0.2%</font>.</li>      <li>U.S. stock futures: Dow <font color=\"red\">-0.4%</font>, S&amp;P <font color=\"red\">-03%</font>, Nasdaq flat.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/efa\" title=\"iShares MSCI EAFE ETF\">EFA</a>, <a href=\"https://seekingalpha.com/symbol/iefa\" title=\"iShares Core MSCI EAFE ETF\">IEFA</a>, <a href=\"https://seekingalpha.com/symbol/vea\" title=\"Vanguard FTSE Developed Markets ETF\">VEA</a>, <a href=\"https://seekingalpha.com/symbol/adrd\" title=\"BLDRS Developed Markets 100 ADR Index ETF\">ADRD</a>, <a href=\"https://seekingalpha.com/symbol/mfla\" title=\"iPath Long Enhanced 2x MSCI EAFE Index ETN\">MFLA</a>, <a href=\"https://seekingalpha.com/symbol/efo\" title=\"ProShares Ultra MSCI EAFE ETF\">EFO</a>, <a href=\"https://seekingalpha.com/symbol/efu\" title=\"ProShares UltraShort MSCI EAFE ETF\">EFU</a>, <a href=\"https://seekingalpha.com/symbol/pdn\" title=\"PowerShares FTSE RAFI Developed Markets ex-U.S. Small-Mid Portfolio ETF\">PDN</a>, <a href=\"https://seekingalpha.com/symbol/piz\" title=\"PowerShares DWA Developed Markets Technical Leaders Portfolio ETF\">PIZ</a>, <a href=\"https://seekingalpha.com/symbol/efz\" title=\"ProShares Short MSCI EAFE ETF\">EFZ</a>, <a href=\"https://seekingalpha.com/symbol/pxf\" title=\"PowerShares FTSE RAFI Developed Markets ex-U.S. Portfolio ETF\">PXF</a>, <a href=\"https://seekingalpha.com/symbol/efg\" title=\"iShares MSCI EAFE Growth ETF\">EFG</a>, <a href=\"https://seekingalpha.com/symbol/efv\" title=\"iShares MSCI EAFE Value ETF\">EFV</a>, <a href=\"https://seekingalpha.com/symbol/dzk\" title=\"Direxion Developed Markets Bull 3X Shares ETF\">DZK</a>, <a href=\"https://seekingalpha.com/symbol/dpk\" title=\"Direxion Developed Markets Bear 3X Shares ETF\">DPK</a>, <a href=\"https://seekingalpha.com/symbol/idlv\" title=\"PowerShares S&amp;P International Developed Low Volatility Portfolio ETF\">IDLV</a>, <a href=\"https://seekingalpha.com/symbol/dth\" title=\"WisdomTree DEFA  Equity Income ETF\">DTH</a>, <a href=\"https://seekingalpha.com/symbol/dwm\" title=\"WisdomTree DEFA  ETF\">DWM</a>, <a href=\"https://seekingalpha.com/symbol/urth\" title=\"iShares MSCI World ETF\">URTH</a>, <a href=\"https://seekingalpha.com/symbol/fdts\" title=\"First Trust Developed Markets ex-US Small Cap AlphaDEX ETF\">FDTS</a>, <a href=\"https://seekingalpha.com/symbol/ezu\" title=\"iShares MSCI EMU ETF\">EZU</a>, <a href=\"https://seekingalpha.com/symbol/vgk\" title=\"Vanguard FTSE Europe ETF\">VGK</a>, <a href=\"https://seekingalpha.com/symbol/fez\" title=\"SPDR EURO STOXX 50 ETF\">FEZ</a>, <a href=\"https://seekingalpha.com/symbol/epv\" title=\"ProShares UltraShort Europe ETF\">EPV</a>, <a href=\"https://seekingalpha.com/symbol/iev\" title=\"iShares Europe ETF\">IEV</a>,  <a href=\"https://seekingalpha.com/symbol/adru\" title=\"BLDRS Europe 100 ADR Index ETF\">ADRU</a>, <a href=\"https://seekingalpha.com/symbol/fep\" title=\"First Trust Europe AlphaDEX ETF\">FEP</a>, <a href=\"https://seekingalpha.com/symbol/fdd\" title=\"First Trust Dow Jones STOXX European Select Dividend 30 Index ETF\">FDD</a>, <a href=\"https://seekingalpha.com/symbol/upv\" title=\"ProShares Ultra Europe ETF\">UPV</a>, <a href=\"https://seekingalpha.com/symbol/epv\" title=\"ProShares UltraShort Europe ETF\">EPV</a>, <a href=\"https://seekingalpha.com/symbol/dfe\" title=\"WisdomTree Europe SmallCap Dividend ETF\">DFE</a>, <a href=\"https://seekingalpha.com/symbol/feu\" title=\"SPDR STOXX Europe 50 ETF\">FEU</a>, <a href=\"https://seekingalpha.com/symbol/feeu\" title=\"Barclays ETN+ FI Enhanced Europe 50 ETN\">FEEU</a>, <a href=\"https://seekingalpha.com/symbol/adra\" title=\"BLDRS Asia 50 ADR Index ETF\">ADRA</a>, <a href=\"https://seekingalpha.com/symbol/aia\" title=\"iShares Asia 50 ETF\">AIA</a>, <a href=\"https://seekingalpha.com/symbol/vpl\" title=\"Vanguard FTSE Pacific ETF\">VPL</a>, <a href=\"https://seekingalpha.com/symbol/asdr\" title=\"VelocityShares Emerging Asia Depositary Receipt ETF\">ASDR</a>. <a href=\"https://seekingalpha.com/symbol/aaxj\" title=\"iShares MSCI All Country Asia ex-Japan Index ETF\">AAXJ</a>, <a href=\"https://seekingalpha.com/symbol/axjs\" title=\"iShares MSCI All Country Asia ex-Japan Small Cap Index ETF\">AXJS</a>, <a href=\"https://seekingalpha.com/symbol/epp\" title=\"iShares MSCI Pacific ex Japan ETF\">EPP</a>, <a href=\"https://seekingalpha.com/symbol/gmf\" title=\"SPDR S&amp;P Emerging Asia Pacific ETF\">GMF</a>, <a href=\"https://seekingalpha.com/symbol/gmfs\" title=\"SPDR S&amp;P Small Cap Emerging Asia Pacific ETF\">GMFS</a>, <a href=\"https://seekingalpha.com/symbol/axjl\" title=\"WisdomTree Asia-Pacific ex-Japan ETF\">AXJL</a>, <a href=\"https://seekingalpha.com/symbol/uxj\" title=\"ProShares Ultra MSCI Pacific Ex-Japan ETF\">UXJ</a>, <a href=\"https://seekingalpha.com/symbol/jpx\" title=\"ProShares UltraShort MSCI Pacific ex-Japan ETF\">JPX</a>, <a href=\"https://seekingalpha.com/symbol/paf\" title=\"PowerShares FTSE RAFI Asia Pacific ex-Japan Portfolio ETF\">PAF</a>, <a href=\"https://seekingalpha.com/symbol/asea\" title=\"Global X FTSE ASEAN 40 ETF\">ASEA</a>, <a href=\"https://seekingalpha.com/symbol/eema\" title=\"iShares MSCI Emerging Markets Asia Index ETF\">EEMA</a>, <a href=\"https://seekingalpha.com/symbol/dvya\" title=\"iShares Asia/Pacific Dividend ETF\">DVYA</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1297632\" data-linked=\"World shares fall on U.S. fears\" data-tweet=\"$EFA $IEFA $VEA - World shares fall on U.S. fears https://seekingalpha.com/news/1297632-world-shares-fall-on-u-s-fears?source=tweet\" data-url=\"https://seekingalpha.com/news/1297632-world-shares-fall-on-u-s-fears\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 AM </div></div></li>","count":61,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}